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Abstract
This work investigates the roles that peptides play in the fields of antimicrobials, surface
functionalization, carbon capture, and biocatalysis. The results demonstrate that peptides,
sometimes dismissed for their lack of complexity, can have a breadth of applications.
First, the killing kinetics of a pore-forming, engineered antimicrobial peptide (CM15) were
imaged using a high-speed atomic force microscope (HS-AFM). The fast time resolution of
the HS-AFM (13 seconds per image) enabled characterization of the initial stages of the
killing of live Escherichia coli cells. The results suggested that the killing process of CM15
is a combination of a time-variable incubation phase and a more rapid execution phase,
offering an interesting parallel between antimicrobial-peptide-induced death and mammalian
cell apoptotic death.
As a follow-up, an engineered peptide (2K1) with high affinity toward oxide surfaces
was used to functionalize a diverse set of materials, including titanium dioxide, zinc, and
stainless steel. After demonstrating that 2K1 works as affinity tag for small molecules and
fusion proteins, a 2K1-CM15 peptide was made in an attempt to develop a single-step, facile
antimicrobial functionalization of oxide surfaces.
Second, motivated by the role of peptides in mineralization processes, the yeast Saccha-
romyces cerevisae was engineered to display peptides and proteins that enhanced the capture
of CO 2 . An industrial-scale CO 2 mineralization process was designed using this engineered
yeast with an associated cost of $52 per tonne of CO 2 . The effect of the engineered yeast
on the process was significant - the cost of CO 2 capture was decreased by 8.5-13.5%, as
compared to a process with no biological components.
Finally, M13 bacteriophage (M13 phage) was established as a temperature stable, highly-
multivalent biocatalytic scaffold through display of engineered histidine-biased peptides. A
protocol for generating histidine-biased peptide libraries displayed on the major coat protein
(pVII) of M13 phage was developed. By analogy to known histidine-based active sites, seven
sequences were chosen from amongst hundreds of sequenced histidine-biased pVIII peptides.
Two demonstrated esterase activity with a Kc~ 170 that matches, and a Km ~ 4 mMKncac
that is only 20-fold lower than, that reported for a commputationally designed esterase.
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High-speed AFM imaging of the
killing kinetics of an engineered
antimicrobial peptide
1.1 Summary
Observations of real-time changes in living cells have contributed much to the field of cellular
biology. Eluding the field thus far had been the ability to image whole, living cells with
nanometer resolution on a time scale that is relevant to dynamic cellular processes. [1, 2]
In this work the kinetics of individual bacterial cell death were investigated using a novel
high-speed atomic force microscope (AFM) optimized for imaging live cells in real time. The
increased time resolution (13 seconds per image) allowed the characterization of the initial
stages of the action of an antimicrobial peptide (AmP) CM15 on individual Escherichia coli
cells with nanometer resolution. The results suggested that the killing process of CM15
is a combination of a time-variable incubation phase (which takes seconds to minutes to
complete) and a more rapid execution phase. The results also offered an interesting parallel
between antimicrobial-peptide-induced death and mammalian cell apoptotic death.1
1.2 Introduction
High resolution AFM images of live cells and cell fragments have resolved the nanoscale
structure of cell walls, the structural dynamics of single spores germinating, the structural
changes of bacteria treated with bactericidal enzymes, and the location of specific binding
sites. [4-9] One of the limitations that made AFM unsuitable for studying many dynamic
processes in cell biology was the long image acquisition time of several minutes for one
high-resolution AFM image. [10] Progress in AFM instrumentation had enabled imaging of
single molecules at up to video rate, but this had been limited to small areas (hundreds
of nanometers) and to flat samples. [11-13] The results in this work resulted from the use
of a high-speed AFM specifically designed to bridge the gap between the improved AFM
'The work presented in this chapter was previously published in Nature Nanotechnology. [3]
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technology and the biologically relevant but challenging experiments interesting to cellular
biology. The key benefit of this instrument was the combination of very soft, but rapid
imaging and a sufficient scan size to monitor multiple cells at once.
AmPs are a promising class of antimicrobials which have demonstrated activity against
antibiotic resistant bacteria, parasites, viruses and fungi. [14-17] Moreover, resistance to
AmPs appears to be much less probably than antibiotic resistance has proven to be. [18]
There are several proposed targets of antimicrobial peptides, including inhibition of cell-wall
synthesis, inhibition of nucleic-acid synthesis, and inhibition of protein synthesis, though the
majority of AmP appear to kill their targets through the formation of transmembrane pore
formation. [19] This class of AmPs have high killing activity against a wide variety of bacteria
and much lower activity against mammalian cells. This is due to an interesting difference
between bacterial and mammalian cell membranes. In bacterial membranes, the outermost
layer exposed to the world is heavily populated with negatively charged phospholipids. In
mammalian cells, though, the outermost layer of the membrane mostly is composed of lipids
with no net charge. Most AmPs are positively charged with clusters of hydrophobic residues.
They are attracted to the negatively-charged outer membrane of bacterial cells and, at critical
concentrations, are able to displace the lipids and disrupt the membrane structure (because
of the hydrophobic residues), sometimes even by forming pores in the membrane. [18]
In this work, a high-speed AFM was used to measure the kinetics of the pre-death activity
of a pore-forming, membrane-disrupting AmP, called CM15, on individual live E. coli cells
in an aqueous solution. CM15 is a well-studied, engineered AmP, comprised of the first
seven amino acids of the from AmP cecropin-A and residues 2-9 from the bee venom AmP
melittin. CM15 has higher potency relative to cecropin A and without the cytotoxic effects
of melittin. Moreover, being only 15 residues long, it is in a size range that is therapeutically
relevant. It has high activity against E. coli (< 1-10 pim, depending on concentration of
cells) and Staphylococcus aureus (2 pm). [20,21]
Prior to this work, electron microscopy and AFM experiments had demonstrated the
endpoint surface morphological changes of a population of cells treated with AmPs. [22-24]
Spectroscopic analyses of synthetic membranes or vesicles had provided insight into the
sizes and structures of pores formed by AmPs. [25-27] However, the early stage kinetics
of the membrane-disrupting activity of an AmP on live cells had not been reported with
nanometer-spatial and seconds-temporal resolution.
1.3 Results
1.3.1 Small cantilevers reduce forces at high imaging speeds
Imaging live bacteria in an aqueous environment is one of the most challenging applications
for AFM. [28] The force interaction between the cantilever tip and the sample is critical; if
the force is too high, the bacteria are damaged or disconnected from the surface, whereas if
it is too low, information about the sample is lost. Maintaining this balance at high imaging
speeds was achieved using prototype AFM components and micro-fabricated small cantilevers
(a 1000 times smaller mass than conventional cantilevers) with integrated tips. [29] These
cantilevers have resonance frequencies in liquid at ~ 100 kHz and spring constants between
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300 and 1000 P. The increased resonance frequency and the reduced mass, quality factor
and spring constant enabled an increased imaging speed in tapping mode while retaining low
imaging forces on the bacteria. [30] Figure 1.1a shows an SEM image of the small cantilevers
used for this research. The inset shows a comparison with a conventional cantilever (NPS-
B, Veeco Metrology). Figure 1.1b shows the thermal spectra of the two cantilevers. The
resonance frequency of the small cantilever is 17 times higher than that of the conventional
cantilever in air and is 30 times higher in fluid.
1.3.2 High-speed AFM imaging of AmP activity on live E. coli
cells in liquid
In this work, bacteria were immobilized on poly-L-lysine coated cover slides. The bacteria
were imaged in aqueous solution for at least 10 minutes to ensure that the cells were not
altered or displaced by the AFM tip and to ensure that the poly-L-lysine did not change the
cells in the timescales observed in our experiments. CM15 was added to the liquid droplet
around the sample to a final concentration of 50 P9 L or >5 times the minimum inhibitory
concentration (MIC) at the concentration of cells being treated (see Table 1.1). Images were
acquired every 13 seconds.
To determine the concentration of the cells on the slide, the average number of cells in
a 100 pm square was determined by averaging the values for several images. This average
"coverage" was then extrapolated across the surface area of the cover slide to determine a
total number of cells. This total number of cells was divided by the volume of the imaging
liquid to provide an estimated concentration of cells (see Table 1.1).
Description Value
Area of disk (pm2 ) 9.42 x 106
Number of cells per square 10 pm 10
Number of cells on disk 9.42 x 106
Volume of liquid (pL) 100
Concentration of cells ( 'g) 9.42 x
MIC of CM15 at 108 e (gs ) 8 [21]
Table 1.1: E. coli concentration in high-speed A FM flow cell and MIC of CM15
Figure 1.2a shows AFM phase images of the surfaces of two bacteria before and at
several times after the addition of CM15. The most apparent effect of the CM15 was that
the surfaces of the bacteria changed from smooth to corrugated. AFM phase data is shown
due to increased clarity in the image. The same changes in surface morphology are present
in AFM amplitude data (Figure 1.3). AFM height data was more difficult to interpret due to
large background variation on the surface of the bacteria. The changes in the surfaces of the
bacteria were consistent with published electron microscopy data that report ultra structural
damage to the outside of peptide-treated bacterial cells. [22-24] Interestingly, there was a
wide range in the time of onset of the change between individual bacteria. Bacterium 1 in
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Figure 1.1: Small AFM cantilevers for high-speed AFM imaging of bacterial cells in liquid
(a) SEM image of the small SiN cantilevers (~ 10 prm wide, 100-350 nm thick, and 20-30
pim long). The inset image compares the small cantilevers (on the right) to a conventional
Veeco NPS-D cantilever used for imaging in fluid (on the left) at the same magnification. (b)
Thermal noise power spectra of regular and small cantilevers. In air (red solid line), the first
resonance frequency of the small cantilever is ~ 350 kHz. In aqueous solution this drops to
100-120 kHz (red dashed line). The inset shows the thermal noise power spectra of an NP-S
cantilever B with resonance frequencies of 21 kHz in air (blue solid line) and 4 kHz in aqueous
solution (blue dashed line). Reprinted with permission from Nature Nanotechnology.
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Figure 1.2: E. coli membrane disruption induced by CM15 imaged with high-speed AFM (a)
Time series of CM15 antimicrobial action. CM15 was injected at t = -6 seconds and images
were recorded every 13 seconds, with a resolution of 1024 x 256 pixels and rate of 20 "i*e.
The upper bacterium's surface started changing within 13 seconds. The lower bacterium
resisted changing for 78 seconds. (b) Larger area view recorded 12 minutes after addition
of CM15. Most bacteria were corrugated but some were still smooth. (c) High-resolution
image of bacterium 3 showed that this bacterium was still smooth at t = 16 minutes. (d)
Image of the now corrugated bacterium 3 at t = 30 minutes. Eventually, all bacteria in the
field of view were affected by CM15. Images were recorded in liquid in tapping mode with
a tapping frequency of 110 kHz. Phase images are shown here for high contrast; amplitude
data is shown in Figure 1.3. Images (b), (c), and (d) were recorded with 1024 x 256 pixels
at 2 1"e. Reprinted with permission from Nature Nanotechnology.
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Figure 1.2a started changing within 13 seconds after addition of CM15 and the change was
completed in ~60 seconds. Bacterium 2 did not start changing until ~80 seconds and the
change was not complete until ~120 seconds.
The phase data was used for the evaluation of the changes in the bacterial surface due to
the increased contrast in these images. Since phase data can also include information about
a change in materials properties it was not possible to absolutely rule out that the contrast
was increased by such a change. However, a change in topography does have a significant
effect on the phase signal, such that obtaining materials properties information from phase
images of samples with significant topography is hardly possible. Also the fact that the
changes in the phase data are somewhat scan-direction dependent (for example comparing
trace and re-trace, data not shown) led to the conclusion that the majority of the features
in the phase signal were due to a change in topography.
Figure 1.2b shows a larger area of the same sample 12 minutes after addition of CM15
bacteria 1 and 2 are in the center of Figure 2b. Some bacteria still had not changed (bacteria
3 and 4). Figure 1.2c is a higher resolution image of the smooth surface of bacterium 3, 16
minutes after addition of CM15. Eventually, this bacterium (Figure 1.2D) and all bacteria
in the field of view became corrugated. Several reasons for the cell-to-cell variation in onset
time were considered. The bacteria were all grown from a single clone, and, thus, were
expected to be genetically identical. They were close to each other (within 10 pn) and
therefore were exposed to the same CM15 concentration at the same time. The cells were
likely not all in the same stage in the cell cycle. However, in all of the experiments, no
correlation between the time of onset of change and cell length (an indicator of stage in cell
cycle) was found. [31]
To ensure that the morphological change observed in this experiment was induced by
CM15, a control experiment with a positively-charged peptide (2K1 from Chapter 2) with
no known antimicrobial action was performed. As demonstrated in Chapter 2, 2K1 has
a very high binding affinity to any negatively charged surface, and so it was expected to
bind to the surfaces of the E. coli cells, but it has no antimicrobial activity on E. coli at
concentrations lower than 200 pm (see Figure 2.8). No morphological change in the cells
was observed, even after 45 minutes of imaging (Figure 1.4).
A second control experiment was performed with the conventional antibiotic ampicillin
(Figure 1.5). Ampicillin inhibits cell wall synthesis, so it would not be expected to induce
the kind of morphological changes caused by a cell-membrane disrupting AmP. As expected,
even after almost 2 hours of imaging, there was still no significant morphological change in
the cells.
1.3.3 AmP-induced surface morphology change correlates with
cell death
To correlate the corrugation of the cell surface with cell death, combined AFM and fluores-
cence microscopy using a fluorescent indicator of cell viability (LIVE/DEAD BacLight) was
performed. Figure 1.6a shows an AFM image of live cells. To minimize disruptions caused
by the AFM tip, the imaging force was reduced until only the tops of the bacteria were
imaged. Figure 1.6b shows a fluorescence image of the same cells recorded immediately after
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Figure 1.3: Amplitude data of full time series from Figure 1.2 Controller gains were set
aggressively to ensure proper tracking of the ROI (region of interest) on top of the bacteria,
which resulted in oscillations in areas where no bacteria were present. Images are 3 pm x 3






-20u --' r - --
0 0.2 0 .4 0.6 0.8 1
Distance (un)
Figure 1.4: AFM images of negative control with 2K1 In order to ensure that the observed
morphology changes are in fact due to the antimicrobial action of CM15 and not just to the
addition of a peptide, 2K1 was used as a control. 2K1 is positively charged, so one would
expect it to bind to the surface of bacterial cells, yet it lacks the hydrophobic regions that
antimicrobial peptides typically have and it has no measurable antimicrobial action at the
concentration used (see Figure 2.8). Phase images before addition of 2K1 (a) and (c) and
45 minutes after addition of 2K1 (b) and (d). The cross-sections in panel (e) showed no
significant difference in the surface variations before and after 2K1 addition. Reprinted with
permission from Nature Nanotechnology.
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Figure 1.5: AFM images of negative control with the antibiotic ampicillin The effect of a
common antibiotic ampicillin on the surface morphology of the E. coli cells was tested.
The columns represent height, amplitude, and phase data, respectively. The rows represent
different time points after addition of ampicillin (no ampicillin, 2 minutes, 108 minutes and
112 minutes after addition of ampicillin). After 112 minutes, minor changes were visible
on the cell surface, but they were much less than that caused by CM15. Reprinted with
permission from Nature Nanotechnology.
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the AFM imaging. Figure 1.6c and 1.6d show the AFM and fluorescence images of the same
bacteria 30 minutes after the cells were exposed to 2 times the MIC of CM15. Almost all
of the bacteria have corrugated surfaces and there are no green (live) cells remaining. The
apparent broadening of the cells is an imaging artifact due to the pyramidal shape of the
tip. [32] There was a strong correlation between the fluorescence and surface variation of the
cells (p-value < 0.004) (see Figure 1.6e).
1.3.4 Quantitative analysis of kinetics of AmP activity
The high time resolution of these measurements enabled the characterization of the initial
stages of antimicrobial action on individual live bacteria. The high-speed AFM experiment
was repeated with a larger scan area to investigate relative differences in the response times
of adjacent cells. At t = 0 seconds, using a flow-through system the imaging solution was
exchanged with solution of CM15 that was twice the MIC. One image was taken every 21
seconds, with every 5th image in Figure 1.7 (full series in Figures 1.8 and 1.9). It is evident
that bacteria 1, 7 and 8 responded more quickly to the addition of CM15 than the other
bacteria.
To quantify the kinetics of the change for each bacterium separately, the change in the
root mean square (RMS) value of the surface corrugation along the long axis of the bacteria
in every frame of the image was measured. Figure 1.7b shows representative cross sections
through bacterium 1 for each image. The change in surface corrugation was visible ~80
seconds after the addition of CM15. Figure 1.7c shows the normalized RMS corrugation
values for the bacteria in Figure 1.7a as a function of time after addition of CM15.
Time of onset of change was highly variable. In this experiment it took 40 seconds
(bacterium 7) to more than 4 minutes (bacterium 2) average of 155 seconds ± 89 seconds
(mean ± standard deviation). The time for each bacterium to complete the change (smooth
to corrugated) was more consistent - 50 % of the damage was completed in 52 seconds ± 16
seconds. Once again, phase data was used for the analysis, since here the changes are most
apparent. The same trends could be observed in the height and amplitude images (Figure
1.10), though they were more difficult to interpret because of the higher background noise in
those images. The CM15-treated cells were monitored for up to 100 minutes after treatment
and no additional changes were observed. Eventually, the cells disappeared, but it was not
possible to say whether this was due to lysis or due to the detachment of cells. Figure 1.7d
shows the results of a measurement of the kinetics of CM15 activity on a population of cells.
The bulk killing rate of CM15 could be described reasonably well with a single exponential
with a half-time of 4.6 minutes.
With this AFM technique, one might expect to see the pores that are formed in the
outer membrane by CM15. The pores formed by CM15 are reported to have diameters of
2-4 nm. [21) Unfortunately, the pixel resolution of the high-speed images is 4-10 nm, scan-
size dependent, and is thus insufficient to see features of this size. Using a slower acquisition
speed (2 i"'nd), images were obtained where the pixel resolution was 1 nm for a 1 pum image
(Figure 1.11). While there are features whose size match the reported pore size of CM15
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Figure 1.6: AmP-induced surface morphology change correlates to cell death Combined AFM
and fluorescence microscopy images recorded on the same spot before and after addition of
CM15. (a) Tapping mode image of bacteria before addition of CM15 (phase data). The
surfaces of most bacteria were smooth. (b) Fluorescence image before addition of CM15.
Green represents live bacteria; red represents dead bacteria (LIVE/DEAD stain). (c) AFM
image 30 minutes after exposure to a solution of CM15 that was 2 times the MIC. Nearly all
the bacteria exhibited a corrugated surface. (d) Fluorescence image after addition of CM15.
All bacteria were red, indicating that they were dead. (e) Cells from (b) and (d) were divided
into a "red" and "green" groups and the average roughness was calculated for each group.
AFM images were taken with 512 x 256 pixels and a scan rate of 0.5 Hz. Reprinted with
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Figure 1.7: Early stage kinetics of CM15 action measured by AFM correlates with bulk killing
activity experiment (a) Time series of bacteria after injection of CM15. Images recorded
every 21 seconds (1024 x 256 pixels, 12.2 lines) with every 5 th image shown (full time series
in Figure 1.8). (b) Cross sections along the long axis of bacterium 1 showing the time
progression of the surface variation. Each slice represents data extracted from one image in
the full time series. (c) Averaged surface variation of the bacteria as a function of time after
injection of CM15 (bacteria numbers correspond to those in frame one of panel (a)). (d)
Bulk measurement of CM15 antimicrobial activity. The interpolated behaviour between 0
and 5 minutes correlated well with the single cell measurements. Reprinted with permission
from Nature Nanotechnology. 22
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Figure 1.8: Phase data of full time series from Figure 1.7 Rotated 90 degrees counter-
clockwise from Figure 1.7(a). Reprinted with permission from Nature Nanotechnology.
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Figure 1.9: Amplitude data of full time sequence from Figure 1.7 Rotated 90 degrees counter-
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Figure 1.10: Analysis of height and amplitude high-speed AFM images for CM15 killing of
E. coli RMS variation was calculated from height and amplitude data in the same manner
as it was for the phase data. These data show the same trends as the values calculated from
the phase images (Figure 1.7c), but the more pronounced features in the phase images result
in better signal to noise ratio. (a) RMS variation calculated from height data as a function of
images after addition of CM15 normalized to the maximum value. (b) Initial height image
immediately after CM15 addition indicating the areas that were used for calculating the
roughness. (c) Normalized RMS variation as calculated from the amplitude images. (d)
Initial amplitude image immediately after addition of CM15. The absolute values of the
final RMS roughness of the height data are 20-30 nm. The absolute values of the final RMS
roughness of the amplitude data is 50-200 nm. The absolute values however varied between
the individual cells which was likely a result of the different orientations of the cells with
respect to the fast scan axis. Reprinted with permission from Nature Nanotechnology.
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Figure 1.11: High-resolution images of the CM15-treated bacteria These images were cap-
tured after the high-speed AFM time series ended for Figure 1.7. The columns represent
height, amplitude and phase data, respectively. The rows represent different magnifications.
The small features have dimensions in the range of the reported CM15 pore sizes, but it can-
not be unequivocally concluded that these features are in fact pores formed by the CM15.




These results led to the hypothesis that the killing of E. coli by CM15 is a two-stage process.
The first stage is a time-variable, and slow to start, incubation phase, which can last seconds
to minutes. The second stage is an execution phase, which is much less time-variable and
which reaches completion more quickly. In the results shown in the work, for example, 50%
of the damage was completed in less than one minute. The time to complete the incubation
phase varies considerably more from cell to cell than the time to complete the execution
phase. This result suggests that the bulk kill rate (e.g., the phenomenon measured in Figure
1.7d) is dominated by the time it takes to complete the incubation phase, rather than the
time it takes to complete the execution phase. This also raises the question of whether the
incubation and the execution phases are prolonged equally in bacteria that are more resistant
to AmPs or if one particular phase is more prolonged than the other. Answering this could
be important for understanding the mechanism by which bacteria can develop resistance to
this class of peptide antibiotics.
The heterogeneity in the dynamics of AmP-induced bacterial cell death has an inter-
esting parallel in eukaryotic cell biology. Mammalian cell apoptotic death recently has
been demonstrated to be a two-stage process comprised of a time-variable and long-in-
duration incubation phase which is followed by a more constant and relatively short exe-
cution phase. [33] Despite the apparent differences in the overall mechanisms between the
two systems, protein/peptide-induced pore formation in a membrane is a critical component
of both mammalian cell apoptotic death (mitochondrial outer membrane permeabilization)
and AmP-induced bacterial cell death (outer membrane permeabilization).
The observation of this two-stage process was made possible by the use of a high-speed
AFM capable of recording dynamic changes on the single cell level. These measurements
demonstrate the enormous potential of high-speed AFM imaging for cellular biology. This
technique can be applied to other cell types such as yeast or mammalian cells and even to
eukaryotic cell organelles and future work with this instrument will surely be focused on
those systems, as well as on additional characterization of AmP-induced killing of bacterial
cells.
1.5 Experimental
1.5.1 Synthesis of the AmP CM15
A well-studied, pore-forming AmP called CM15 with the sequence KWKLFKKIGAVLKVL
was used. The peptide was made by Genscript (Piscataway, NJ, USA) using standard solid
phase peptide synthesis methods, was purified by desalting and was shipped lyophilized.
The peptide was resuspended and stored in Millipore water and diluted to the appropriate
concentrations in Millipore water.
1.5.2 Bacteria preparation
E. coli bacteria (ATCC 25922) were grown from a single colony overnight in LB growth
medium at 37 degrees Celsius. Cells were diluted 1:100 in fresh LB medium and were grown
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for 3 hours. Cells were spun down and washed three times with Millipore water.
To increase adherence of the bacteria to the glass substrate, glass cover slips were coated
with poly-l-lysine before depositing the bacteria. Round glass cover slips were boiled in 2.5
M HCl solution for ten minutes to clean the glass. The cover slips were rinsed six times
with Millipore water and were immersed for ten minutes in a pH 8.0 solution of 0.05 '
poly-L-lysine hydrobromide (Sigma part number: P1524) and 10 mM Tris. Afterwards, they
were covered and dried vertically overnight at room temperature. The coated cover slips
were stored at room temperature and were used within one week.
Concentrated bacteria suspended in un-buffered Millipore water were deposited on the
coated cover slips and incubated for 30 minutes. Excess cells were rinsed off with 3 washes
of 1 ml Millipore water. Images were taken in Millipore water.
1.5.3 High-speed AFM imaging
All high-speed AFM images were taken on a customized AFM instrument based on a Veeco
Multimode with a Nanoscope 5 controller (Veeco Metrology, Santa Barbara, USA). The most
enabling modifications are small cantilevers (SCL-Sensor.Tech. fabrication GesmbH, Vienna,
Austria) and a new AFM head designed for use with the small cantilevers. A high-speed
scanner was not used for these experiments, since turnaround ripples and other distortions
were small at these scanning parameters. All measurements were performed in tapping
mode in fluid with an open fluid cell. Flow-through fluid exchange was achieved using a
dual syringe pump. Height, amplitude and phase signals were recorded for both trace and
retrace. The data was processed using ImageJ, ImageSXM and Gwyddion, using standard
modification commands applied over the whole sample.
1.5.4 Quantification of bacterial surface morphological changes
To quantify the change in the variations on the bacterial surface, line sections were extracted
from the phase data on the top of each bacterium in the longitudinal direction. The exact
number of line sections per bacterium per image depended on the size of the bacterium but
was always more than 20. A 3 rd degree polynomial was fit through each line section and
subtracted from the original data. The resulting data represented only the higher spatial
frequencies from which the RMS value was calculated. The RMS values of each line were
then averaged over all the lines along the bacterium. This number represents one data
point in Figure 1.7. The error bars represent standard deviation of this calculation when
varying the exact area on each bacterium and the number of longitudinal sections used for
the calculation. This calculation was repeated for each frame in the time series and for each
cell. The data processing was done with custom software written in Labview and NI-Vision
(National Instruments, Austin, USA).
1.5.5 Combined AFM/fluorescence microscopy imaging
AFM images were recorded on a Digital Instruments Bioscope (Veeco Metrology Inc., Santa
Barbara, USA) with an extended Nanoscope 3a controller, mounted on top of a Zeiss Axiovert
135 inverted microscope (Carl Zeiss Microimaging GmbH, Germany). AFM images were
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taken with a Veeco NPS cantilever in tapping mode (Veeco Instruments Inc., Camarillo,
USA). Fluorescence images were recorded using a Zeiss 1OOX Plan-Neofluar oil immersion
objective and a Chroma Technology Corporation (Rockingham, USA) filter set 41012 . Cells
were stained with LIVE/DEAD BacLight stain (Invitrogen PN: L13152). The LIVE/DEAD
stain is a mixture of SYTO 9 green-fluorescent nucleic acid stain and propidium iodide
red-fluorescent nucleic acid stain. These stains differ in their ability to penetrate healthy
bacterial cells, with the green stain permeating healthy cells and the red stain permeating
membrane-compromised cells.
Due to the loss in viability during the preparation process, some cells already are dead
before the experiment starts (see Figure 1.6). During initial AFM imaging, some loosely
connected cells detach from the surface and therefore not all the cells in Figure 1.6a are
present in Figure 1.6b.
1.5.6 Analysis of LIVE/DEAD stain results and correlation with
bacterial surface morphological changes
Fluorescence images were analyzed using ImageJ with nucleus counter plug-in (downloaded
from MacBiophotonics). Cells were identified and numbered using the nucleus counter plug-
in. The color images were split into red, green, and blue channels. For each cell, the mean
red and the mean green values were measured and the green to red ratio for each cell was
calculated. The cells were divided into two populations - those with green to red ratios less
than one (dead) and those with green to red ratios greater than one (live). Using the axial
RMS variation for each cell (calculation described below), a one-tailed students t-test was
used to assess whether the live cell population and the dead cell population had statistically
different RMS variation values.
1.5.7 Bulk cell killing assay
Cells were grown overnight in LB from a single colony. In the morning, they were diluted
1:100 in fresh LB and grown for three hours. After three hours, they were washed three times
in Millipore water. The washed cells were resuspended in Millipore water to a concentration
of 2x106 cell. The CM15 peptide was added to the cells to a final concentration of 20 P,mL~ mL'
which was the same peptide-to-cell ratio as that used in the AFM experiments. Aliquots were
taken from the cells at various time points and were plated in triplicate on fresh, prewarmed
LB agar plates, which were incubated overnight at 37'C. The number of colonies formed is
an indicator of the number of viable cells remaining in the suspension at each time point.
The number of colonies formed was counted and the average and standard deviation of each




Functionalization of oxide surfaces
with an engineered peptide
2.1 Summary
Peptide affinity tags are useful for facile surface functionalization of materials with proteins
and other biomolecules. By directly interacting with the surfaces, peptide affinity tags obvi-
ate the need for multistep chemical surface functionalization. Affinity peptide tags are often
also reversible, which allows for easier surface cleaning than covalent chemical functional-
izations require, while still retaining high binding strength. In this work, applications for
a novel peptide affinity tag (2K1) with high affinity for metal oxide surfaces were explored.
The versatility of this peptide affinity tag was demonstrated by functionalization of a di-
verse set of relevant materials, including titanium dioxide, zinc, and stainless steel. The 2K1
peptide was used as an affinity tag for a small molecule (biotin) and for two larger fusion
proteins (basic fibroblast growth factor and protein A). Finally, a 2K1-CM15 peptide was
made in an attempt to develop a single-step, facile antimicrobial functionalization of oxide
surfaces.
2.2 Introduction
The development of peptides with high affinities for medically and industrially relevant ma-
terials is of growing interest, especially as the field of synthetic biology promises to continue
to bring down the costs of DNA and protein synthesis. [34, 35] Despite the advantages that
peptide affinity tags offer (single-step, reversible fuctionalization in aqueous chemistry) there
are still a limited number of peptide tags with high affinities toward relevant materials. One
such set of materials with limited options for peptide-driven fuctionalization is metal oxides,
which span the application areas from stainless steel industrial reactors to dental implants
made of aluminum oxide.
In this work, the versatility and utility of a high-affinity sapphire-binding peptide (2K1)
was explored. 2K1 had been shown previously to enable the immobilization of an MBP-
fusion protein to sapphire, SiO 2 , and tissue culture treated polystyrene (TCT-PS). [36)
The range of substrates has now been expanded to three additional ubiquitous metal oxide
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surfaces. A biotin-2K1 fusion was made and used to demonstrate the immobilization of a
streptavidin-conjugated horseradish peroxidase (HRP) enzyme to TCT-PS, TiO 2 , zinc metal,
and stainless steel.
Additionally, 2K1's utility as affinity tag in two different recombinantly-produced fusion
proteins was demonstrated, each with relevant biotechnology applications. The first was
protein A (protA), which binds to the Fc region of IgG molecules, thus making it a useful
alternative to biotin-streptavidin interactions for capturing or immobilizing antibodies. [37]
The second was basic fibroblast growth factor (bFGF), which binds heparin. [38] Heparin
acts as an anticoagulant and is given to patients during several types of medical treatments,
including heart surgeries and hemofiltration. It is critical to monitor heparin levels in the
blood, and one can imagine the utility of functionalizing a highly sensitive detector (such
as the suspended microchannel resonator pioneered by the Manalis group at MIT) with a
molecule that can recognize and bind heparin. [39]
Finally, fusions of 2K1 and the antimicrobial peptide investigated in Chapter 1, CM15,
were made in an attempt to make antimicrobial surfaces. CM15 was chosen as the peptide
of interest for these fusions because it is relatively short, thus keeping the synthesis costs
within reason.
2.3 Results
2.3.1 Expression and purification of 2K1 fusion proteins
The 2K1 peptide was expressed on the C-terminus of two different MBP fusion proteins,
one with the IgG-binding fragment of protA on the N-terminus and one with the heparin-
binding fragment of bFGF. The fusion proteins were then expressed and purified in E. coli
cells as described in Section 2.5.3. Figure 2.1 shows Coomasie stained gels with the different
fractions from the purification. Since the expression vector that was used has a His6 tag,
a Ni-NTA column was used to purify the fusion proteins (with an imidazole elution). The
2K1-MBP-protA and 2K1-MBP-bFGF fusion proteins have estimated molecular weights of
~ 63 and 65 kDa, respectively. Proteins of these sizes would be expected to migrate between
the second and third bands in the protein ladder (80 kDa and 58 kDa), which was confirmed
by visual inspection of the gels.
To confirm that the bands in the Coomasie-stained gels were the fusion proteins, the
two or three fractions that appeared the most pure were analyzed with Western blots using
Anti-MBP and with PentaHis antibodies. Images of those gels can be seen in Figure 2.2.
This analysis confirmed that the MBP and His6 portions of the fusion proteins were present.
For further analysis, the highest concentration fractions at the highest purity were used. For
2K1-MBP-protA, the 200 mM imidazole fraction was used at an estimated concentration of
- 44.5 pM. For 2K1-MBP-bFGF, the 70 mM imidazole fraction was used at an estimated
concentration of a 5.8 pM (see Section 2.5.8 for details on calculating concentrations).
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surfaces. A biotin-2K1 fusion was made and used to demonstrate the immobilization of a
streptavidin-conjugated horseradish peroxidase (HRP) enzyme to TCT-PS, TiO2 , zinc metal,
and stainless steel.
Additionally, 2K1's utility as affinity tag in two different recombinantly-produced fusion
proteins was demonstrated, each with relevant biotechnology applications. The first was
protein A (protA), which binds to the Fc region of IgG molecules, thus making it a useful
alternative to biotin-streptavidin interactions for capturing or immobilizing antibodies. [37]
The second was basic fibroblast growth factor (bFGF), which binds heparin. [38] Heparin
acts as an anticoagulant and is given to patients during several types of medical treatments,
including heart surgeries and hemofiltration. It is critical to monitor heparin levels in the
blood, and one can imagine the utility of functionalizing a highly sensitive detector (such
as the suspended microchannel resonator pioneered by the Manalis group at MIT) with a
molecule that can recognize and bind heparin. [39]
Finally, fusions of 2K1 and the antimicrobial peptide investigated in Chapter 1, CM15,
were made in an attempt to make antimicrobial surfaces. CM15 was chosen as the peptide
of interest for these fusions because it is relatively short, thus keeping the synthesis costs
within reason.
2.3 Results
2.3.1 Expression and purification of 2K1 fusion proteins
The 2K1 peptide was expressed on the C-terminus of two different MBP fusion proteins,
one with the IgG-binding fragment of protA on the N-terminus and one with the heparin-
binding fragment of bFGF. The fusion proteins were then expressed and purified in E. coli
cells as described in Section 2.5.3. Figure 2.1 shows Coomasie stained gels with the different
fractions from the purification. Since the expression vector that was used has a His6 tag,
a Ni-NTA column was used to purify the fusion proteins (with an imidazole elution). The
2K1-MBP-protA and 2K1-MBP-bFGF fusion proteins have estimated molecular weights of
- 63 and 65 kDa, respectively. Proteins of these sizes would be expected to migrate between
the second and third bands in the protein ladder (80 kDa and 58 kDa), which was confirmed
by visual inspection of the gels.
To confirm that the bands in the Coomasie-stained gels were the fusion proteins, the
two or three fractions that appeared the most pure were analyzed with Western blots using
Anti-MBP and with PentaHis antibodies. Images of those gels can be seen in Figure 2.2.
This analysis confirmed that the MBP and His6 portions of the fusion proteins were present.
For further analysis, the highest concentration fractions at the highest purity were used. For
2K1-MBP-protA, the 200 mM imidazole fraction was used at an estimated concentration of
a 44.5 pM. For 2K1-MBP-bFGF, the 70 mM imidazole fraction was used at an estimated
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Figure 2.1: SDS-PAGE of 2K1-MBP-bFGF-His6 fractions and 2K1-MBP-protA-His6 frac-
tions The gel on the left is a Coomasie stained gel of the 2K1-MBP-bFGF-His6 cell lysate
with the different imidizole elution fractions listed from left to right. The gel on the right is
a Coomasie-stained gel of the 2K1-MBP-protA-His6 cell lysate with the different imidizole
elution fractions listed from left to right. The protein ladder is NEB Prestained Protein
Marker, Broad Range (7-175 kDa).
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Figure 2.2: Anti-MBP western blot of 2k1-MBP-bFGF-His6 fractions and PentaHis western
blot of 2K1-MBP-bFGF-His6 fractions The image on the left is a western blot using an anti-
MBP antibod. The image on the right is a western blot using a PentaHis antibody. Both
western blots confirm the presence of the 2K1-MBP fusion proteins in the fractions. The
protein ladder is NEB Prestained Protein Marker, Broad Range (7-175 kDa).
2.3.2 2K1 peptide can be used as an affinity tag in fusion proteins
Once the expression and purification of 2K1 fusion proteins in an E. coli host was confirmed,
the ability of the 2K1 peptide to immobilize and properly orient the fusion proteins on TCT-
PS was tested. 2K1 had already been demonstrated to have a high affinity for the negatively
charged oxide surface of plasma treated polystyrene, and this is an easy surface on which to
perform binding assays. [36] Figures 2.3 and 2.4 show the results of these binding assays, as
well as cartoons describing the layout of the binding assays. Both of the fusion proteins were
able to capture and immobilize their target molecules (IgG and heparin) on the TCT-PS
substrate with high affinities (KD << 100 nM). The KD's for these fusion proteins were
not calculated, because of the variability introduced by the fusion protein concentration
and purity calculations. A visual inspection of the data, however, suggests that the KD is
between 10 nM and 30 nM.
The His6 tag that is present on the 2K1 fusion proteins was used only as a purification
tag, and it did not have a detectable effect on the immobilization of the fusion proteins to
TCT-PS. If, however, these proteins were to be used in future applications, the expression
vector encodes a thrombin cut site between the His6 tag and the rest of the fusion protein,
which could be used to remove the His6 tag.
2.3.3 2K1 enables binding to a variety of oxide surfaces
Since 2K1 had already been demonstrated to have a high affinity to more than one type of
oxide surface, including SiO 2 , A12 0 3, and TCT-PS, the promiscuity of the peptide's binding
was tested using several additional materials. A panel of four ubiquitous metals were tested















Figure 2.3: Binding of 2K1-MBP-bFGF fusion protein to TCT-PS To test the ability of
a 2K1 affinity tag to immobilize and properly orient a bFGF moiety to an oxide surface,
a modified ELISA was set-up. The 2K1 fusion protein was immobilized on the bottom
of TCT-PS wells in a 96-well plate. The bFGF moiety was used to capture a fluorescein
heparin conjugate, and the capture of this target was verified using an anti-fluorescein-HRP
conjugate. After 5 minutes of exposure to TMB, the signal was read in a plate reader at 650










Figure 2.4: Binding of 2K1-MBP-protA fusion protein to TCT-PS To test the ability of
a 2K1 affinity tag to immobilize and properly orient a protA moiety to an oxide surface, a
modified ELISA was set-up. The 2K1 fusion protein was immobilized on the bottom of TCT-
PS wells in a 96-well plate. The protA moiety was used to capture a rabbit anti-streptavidin
IgG, and the capture of this target was verified using a streptavidin-HRP conjugate. After
5 minutes of exposure to TMB, the signal was read in a plate reader at 650 nm and the
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binding of the protA fusion protein to TiO 2 , stainless steel, and zinc (Figure 2.5). There was
no detectable binding to the iron bar, though it should be noted that the iron bar appeared
to be reacting with the binding solution and bits of iron were flaking off into the solution,
which would have prevented the formation of a peptide layer on the surface of the bar. The
results of this binding assay were not quantitative, because each of the materials used was
a different size with different surface areas. Rather, this was meant to provide a qualitative
assessment of whether 2K1 would bind to these materials. Further characterization of the
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Figure 2.5: Binding assay for 2K1 to other metals Since 2K1 had already been shown to
bind to Si0 2 , sapphire, and TCT-PS, additional oxide surfaces were tested. As expected,
2K1 also showed a binding affinity for zinc, TiO2 , and stainless steel. Each of these materials
forms an oxide layer on the surface in aqueous solutions, and it is to this oxide layer that
2K1 is likely binding. The lack of binding to zinc was likely due to the reaction of the zinc
metal with the aqueous binding solution and the constant sluffing off of the outer layers
during binding.
2.3.4 2K1-biotin enables single-step biotinylation of stainless steel
Adhesion of microorganisms to material surfaces occurs in a variety of contexts, often with
deleterious effects. For example, biofilms form in industrial processes where they clog pipes
or enhance corrosion. [40,41] In the food processing industry, biofilms are associated with
contamination of surfaces and transmission of infectious diseases, while biofilms on medical
devices can provide safe harbor for antibiotic resistant pathogenic bacteria. [42,43].
Stainless steel is a steel alloy that does not corrode or rust as easily as normal steel,
due to the presence of ~ 11% chromium by mass. It is the chromium that protects the
bulk of the material through the formation of a thin oxide layer on the surface. There are
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over one hundred grades of stainless steel and it is available in a plethora of forms: sheets,
bars, wires, pipes, etc. Due to this availability and the inherent advantages over normal
steel, it is used widely, including in the medical device and food processing industries. Thus,
a facile means of functionalizing stainless steel is of obvious value. Several groups have
reported on chemical approaches or adsorption to stainless steel functionalization to reduce
biofouling. [44-461 Others have used polyelectrolyte layers to confer antimicrobial properties
to stainless steel for medical implants. [47]
After demonstrating that the 2K1 peptide could bind to stainless steel, the next step was
to assess the binding affinity. A 2K1 peptide with biotin attached to the C-terminus was
synthesized using solid phase chemical synthesis (Genscript, Piscataway, NJ). The binding
affinity of 2K1-biotin was measured as described in Section 2.5.7 and the results can be
seen in Figure 2.6 and the relative binding affinity of 2K1 to a variety of oxide surfaces is











Figure 2.6: Measurement of binding affinity of 2K1 to stainless steel Stainless steel forms
a chromium oxide layer on the surface in aqueous solutions. 2K1 has a KD of ~ 36 nM to
stainless steel, which is the highest affinity for a small peptide to a stainless steel that has
been reported.
The measured binding affinity of 2K1 to stainless steel is 36 nM ± 10 nM. Interestingly,
this affinity is very comparable to one of the most widely used affinity tags available: His6
has an affinity for Ni-NTA plates of 30 ± 3 nM when measured using a similar assay. [36)
Overall, it appears that 2K1 is a versatile affinity peptide for the functionalization of oxide
materials. It can be used as an affinity tag in fusion proteins, or, if it has a biotin attached
to it, it can be used for facile biotinylation of oxide surfaces. The binding affinities are in
the low to mid nM ranges for A12 0 3 , TCT-PS and stainless steel. These results lead to
the expectation that other highly negatively charged oxide or phosphate surfaces would also




A-face sapphire (A12 0 3 ) +++ (KD =1.3 t 0.3 nM) [36]
Tissue culture treated polystyrene (TCT-PS) +++ (KD = 1.5 ± 0.1 nM) [36]
Z-cut quartz (single crystal Si0 2 ) +++"
TiO 2  +++
Stainless steel ++ (KD = 36 i 10 nM)
Thermally grown 100 nm SiO 2 layer on Si wafer ++a
Zinc 
Standard borosilicate glass +a
Iron
His6-tag on Qiagen Ni-NTA HisSorb plate ++ (KD= 30 ± 3 nM)a
Table 2.1: 2K1 surface binding versatility The material binding promiscuity of 2K1 is sum-
marized. 2K1 binds with low nM affinity to sapphire and TCT-PS and mid nM affinity to
stainless steel. The affinities to Si0 2 and TiO 2 were not calculated, but 2K1 showed strong
binding to each in a qualitative assay. The lack of binding to zinc was likely due to the
reaction of the zinc metal with the aqueous binding solution and the constant sluffing off of
the outer layers during binding.
2.3.5 Functionalization of TCT-PS with antimicrobial peptide us-
ing 2K1
Finally, with the goal of establishing a protocol for single-step and facile antimicrobial func-
tionalization of oxide surfaces, a fusion peptide of 2K1 and the AmP CM15 was made. The
fusion peptide was synthesized using solid phase chemical synthesis (Genscript, Piscataway,
NJ). To test the ability of this fusion peptide to make antimicrobial surfaces, peptides were
incubated with TCT-PS at four concentrations (3.1-200 pM) for one hour. To confirm that
the concentrations of peptides were sufficient to achieve full surface functionalization, the
KD's were measured for CM15 (39 ± 15 nM) and 2K1 (3.8 ± 1.3 nM) to TCT-PS (see Figure
2.7. These results confirmed that even the lowest concentration used in the antimicrobial
assay is still at least two orders of magnitude higher than the KD'S of both peptides. For
the subsequent assays, four peptide conditions were tested: no peptide on surface (i.e., bare
TCT-PS), 2K1 on surface, 2K1-CM15 fusion peptide on surface, and CM15 on surface.
There were two assays of antimicrobial activity that were performed with the functional-
ized TCT-PS. The first assay was a test of the ability of the funtionalized surfaces to inhibit
growth of E. coli cells in a suspension culture. The concentration of mid-log phase growing
E. coli cells was monitored over a four hour period. At the end of the time period the
fold-growth for each concentration and type of peptide was calculated.
The results of this assay are shown in Figure 2.8a. There was no discernible difference
between the wells with no peptide and the 2K1-biotin peptide, and they all had between
2- and 2.5-fold increases in E. coli concentration. The 2K1-CM15 functionalized surfaces
appeared to keep the concentration of the cells at around the starting concentration for all
four concentrations of 2K1-CM15. The results showed that the CM15 alone was able to
inhibit growth as well as the 2K1-CM15 at the lower concentrations and performed even
better than the 2K1-CM15 at the higher peptide concentrations. At 200 pM peptide, the
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Figure 2.7: Binding affinity of 2K1 and CM15 on TCT-PS To confirm that the concentra-
tions of peptides used in the antimicrobial assays would provide sufficient surface function-
alization, the binding affinity of 2K1 and CM15 to TCT-PS was measured.
CM15 alone actually reduced the concentration of cells to below the detection limit of the
assay, whereas the 200 pM 2K1-CM15 only succeeded in holding the concentration of cells
constant. This difference is likely due to the fact that the CM15 has a higher KD than the
2K1-CM15. A higher KD would lead to faster off-rates and over a 4 hour period some of the
peptide might have leached off the surface and into the solution, where it killed the cells.
The second assay was a measurement of what fraction of the cells that had adhered to
the TCT-PS surface were alive. These cells are the likely progenitors of biofilms; they are
the first colonizers that lead to downstream economic damages and health complications on
medical devices, in industrial processes and in food processing plants. [40-43] If a surface
can be functionalized such that fewer bacteria can colonize it, then these effects could be
minimized. To measure this, the peptide-treated TCT-PS wells from the growth inhibition
experiment were washed thoroughly to remove any unbound cells. The remaining cells were
stained with a LIVE/DEAD stain. A fluorescence microscope was used to capture images
of the stained bacteria. The images were processed as described in Section 2.5.9 and a
green:red (LIVE:DEAD) ratio was calculated for each well. Multiple images per well and
replicate wells were all averaged together and the results are presented in Figure 2.8b. Only
the highest concentration of CM15 had a higher "dead" signal than "live" signal, and the
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Figure 2.8: Using 2K1 to functionalize TCT-PS with an antimicrobial peptide (a) Peptide-
functionalized TCT-PS was tested for its ability to inhibit growth of a suspension of mid-log
phase E. coli cells over a four hour period in LB at 37*C. At lower peptide concentrations, the
2K1-CM15 fusion protein performed comparably to CM15 only, but at higher concentrations,
the CM15 had a more dramatic impact on the E. coli cells. (b) For the three highest
concentrations of peptide the wells from the assay in (a) were washed to remove unbound
cells and then stained with a LIVE/DEAD stain to determine viability of adherent bacterial
cells. For all three peptide concentrations, there were more live cells for the 2K1-CM15
surfaces than for the CMl5 only surfaces and only at the highest concentration of peptide
did CM15 wells have more dead than live cells.
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2.4 Conclusions
The versatility and utility of an oxide surface binding peptide (2K1) was demonstrated.
2K1 was shown to bind to a wide range of materials, including A12 0 3 , SiO 2 , TCT-PS,
TiO2 , stainless steel, and zinc. [36] 2K1 can be used as an affinity tag in fusion proteins
and it was shown to properly orient and immobilize two ubiquitous biomolecules (bFGF
and protA). Alternatively, a biotinylated version of the peptide alone can be used to easily
functionalize oxide surfaces, which opens the door to the biofuncationalization of a wide
array of industrially relevant materials. The utility of 2K1-AmP fusion peptides in making
antimicrobial TCT-PS surfaces and inhibiting bacterial colonization was investigated. Due
to the fact that the AmP that was used in these assays already has an affinity for negatively-
charged TCT-PS and because the mechanism of AmP action requires that the peptides be
in solution in order to form pores on the cells surfaces, there were no perceived advantages
in using 2K1-AmP fusions.
2.5 Experimental
2.5.1 Materials
Type 304 stainless steel and titanium (IV) oxide were purchased from AlfaAesar. Stainless
Steel foil was purchased as 0.1 mm (0.004 in) thick, Type 304 100 x 100 mm, Fe:Cr:Ni 70:19:11
wt% (stock number: 41583) and was then cut into 0.14 inch squares (for the initial binding
experiments) or punched into 3/16 inch circles using a Precision Brand Punch and Die Set
(for the KD and koff measurements). Titanium dioxide was purchased from AlfaAesar as
naturally occurring mineral grains, approximately 0.06-0.19 inches (stock number: 42648).
Iron was used as 5 mm x 3 mm x 3 mm bars and zinc was used as 2.5 mm x 6 mm x 1 mm
bars.
2.5.2 2K1 fusion proteins cloning and analysis
To build 2K1-MBP-protA and 2K1-MBP-bFGF expression constructs, 2K1-MBP-protA and
2K1-MBP-bFGF were cut from pMAL-c2x plasmid using NdeI and HindIII restriction en-
zymes. The purified insert DNA was then ligated into the pET-28A plasmid using NdeI and
HindIII restriction sites such that the fusion protein was downstream of the His-Tag in the
pET-28a plasmid (for example: N-terminus His6-bFGF-MBP-2K1C-terminus). Plasmids were
transformed into BL21(DE3) cells and plated on kanamycin plates. Proper sequences were
confirmed through DNA sequencing of purified plasmid DNA from single colonies. Initial
expression of fusion proteins was determined by growing cells at 37'C picked from a single
colony for 4 hours in 25 mL of LB plus kanamycin. IPTG then was added to a final concen-
tration of 1 mM to initiate induction of the fusion proteins and cells were grown for another
2.5 hours at 370 C. 200 pL aliquots were added to 140 pL of 1x PBS / 1 M NaCl and were
frozen at -20 C overnight. These cell lysates (or more dilute version if still too thick too load
on a gel) were then run directly on SDS-PAGE gels with LDS sample buffer and reducing
agent. Expression was confirmed with coomasie staining and western blotting. Glycerol
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stocks of cells with expression plasmids were made by adding 100 pL of 75% glycerol to 900
pL of exponential phase cells (OD60 0 = 0.5-0.75).
2.5.3 2K1 fusion proteins expression and purification
Cells containing the appropriate expression plasmids were seeded into 500 mL TB plus
kanamycin at 9 OD60 0 / 500 mL. Once the OD60 0 reached 0.5 IPTG was added to a final
concentration of 1 mM and the heater in the shaker was turned off to allow for overnight
expression of proteins at room temperature. The next day the cells were pelleted by centrifu-
gation (50OOg for 10 min). Pellets were resuspended in 5 mL lysis buffer (20 mM imidazole,
pH 7; 4 mM MgCl2 ; 10 mM mercapto ethanol; 0.02 m Peptstatin A; 0.2 m TPCK; 0.2 m
TAME; 0.02 m leupeptin; 0.2 m soybeans; 20 mM PMSF in water). Cell suspension was
incubated on ice for 30 minutes, frozen in liquid nitrogen and stored at -90'C overnight. The
next day the frozen cells were thawed with alternating 2 minute exposures to a 37'C water
bath with agitation and ice. The 37'C / ice procedure was repeated three times, then the
cells were frozen in liquid nitrogen and the thawing cycle was repeated. This freeze / thaw
cycle was performed three times. RNAse (0.5 mL of Sigma R5000) and DNAse (0.25 mL of
Sigma D4527) were added to the lysates and the samples were incubated for 30 minutes on
ice on a slowly tilting shaker. The solutions were then spun at 21,800g for 20 minutes and
the pellets were discarded. The supernatent was spun at 180,000g for 30 minutes at 4C.
The supernatent was then added to 2 mL of pre-equilibrated Ni-NTA resin (Qiagen Ni-
NTA Superflow) and were incubated overnight on a rotating shaker. The next day the
resin/supernatent mixture was added to a clean column. Resin was washed with 20 mM
imidazole pH 7, 4 mM MgCl 2 . Eluent was collected and protein content was monitored with
Bradford reagent. Resin was washed until no protein eluted. Fractions were then eluted
from column with increasing concentrations of imidazole in 4 mM MgCl 2 , 10 mM #ME (70
mM imidizole - 500 mM imidizole). Fractions were analyzed by SDS-PAGE and fractions
with high purity of fusion proteins were concentrated in a Vivaspin Centricon 15 (MW cutoff
30 kDa) and were doubly buffer exchanged into 1x PBS, pH 7.2.
The Edlehoch model was used to calculate the extinction coefficients of the two fusion
proteins. [48]. Extinction coefficients of 67280 and 79850 at 280 nm were calculated for
2kl-MBP-protA and 2K1-MBP-bFGF, respectively. The 200 mM imidazole fraction for
2K1-MBP-protA was used for further binding analysis, with a calculated MW of 63298
grams. The 150 mM imidazole fraction for 2K1-MBP-bFGF was used for further binding
mole
analysis, with a calculated MW of 65149 grams
mole
2.5.4 2K1-MBP-protA and 2K1-MBP-bFGF testing
TCT-PS wells (BD Falcon 35-3072 96-well plate) were incubated for 1 hour in 200 pL of
protein dissolved in 1x PBST with 0.1% Tween (PBST). For 2K1-MBP-protA, the wells
were washed three times each in 200 pL PBST and were then incubated for 1 hour with 200
piL of 500 9 rabbit anti-streptavidin in 1x PBS with 5 m BSA (PBS/BSA). The wells were
washed three times with 200 pL PBST and were incubated with 200 pL of a 1:1000 dilution
of a 1 9 Streptavidin-HRP (SAv-HRP; Upstate 18-152) in PBST for 1 hour. This was
followed by three washes with PBST. Finally, the wells were incubated with 150 pL of TMB
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substrate. After 5 minutes, the absorbance at 650 nm was measured. Each concentration
and protein combination was measured in duplicate.
For 2K1-MBP-bFGF, the wells were washed three times each in 200 pL PBST and were
then incubated for 4 hours with 200 pL of 500 ng/mL heparin-fluorescein in 1x PBS with
5 m BSA (PBS/BSA). The wells were washed three times with 200 pL PBST, and were
incubated with 200 pL of a 1:1000 dilution of a 1 m anti-fluorescein-HRP (PerkinElmer
NEF710001EA) in PBS/BSA for 1 hour. This was followed by five washes with PBST.
Finally, the wells were incubated with 150 pL of TMB substrate. After 5 minutes, the
absorbance at 650 nm was measured. Each concentration and protein combination was
measured in duplicate.
2.5.5 2K1 binding to other metals
Metal samples were incubated for 3 hours in 200 pL of protein dissolved in 1x PBST with
0.1% Tween (PBST) in a 96-well plate well. The samples were washed three times each in
500 pL PBST in a 48-well plate and were then incubated for 45 minutes with 500 ' rabbit
anti-streptavidin in 1x PBS with 5 m BSA (PBS/BSA). The samples were moved to a clean
96-well plate, were washed five times with 200 pL PBS/BSA, and were incubated with 200
pL of a 1:1000 dilution of Streptavidin-HRP (SAv-HRP) in PBS/BSA for 30 minutes. This
was followed by five washes with PBST. Finally, the samples were transferred to clean wells
and were incubated with 200 pL of TMB substrate. After 15 minutes, the samples were
removed from the wells and the absorbance at 650 nm was measured. Each sample and
protein combination was measured in duplicate.
2.5.6 2K1-biotin and 2K1-CM15 peptide synthesis
The peptides were made by Genscript (Piscataway, NJ, USA) using standard solid phase
peptide synthesis methods, were purified by desalting and were shipped lyophilized. The
peptide was resuspended and stored in Millipore water and diluted to the appropriate con-
centrations in Millipore water. Analysis of the HPLC traces included with the peptides
showed that the 2K1-CM15 peptide was roughly 60% pure and the 2K1-biotin peptide had
> 95% purity. Peptide synthesis was verified by MS analysis by Genscript. 2K1-CM15 had
a 4 glycine linker between the 2K1 and the CM15 moieties.
2.5.7 2K1-biotin binding to stainless steel
Stainless steel circles were incubated for 1 hour in 200 pL of protein dissolved in 1x PBST
with 0.1% Tween (PBST) in a 96-well plate well. After addition of the protein solution, each
stainless steel circle was checked to ensure that no air bubbles were blocking the surfaces.
The samples were washed three times each in 200 pL PBST and were incubated with 200 PL
of a 1:1000 dilution of Streptavidin-HRP (SAv-HRP) in PBS/BSA for 30 minutes. This was
followed by five washes with PBST. Finally, the samples were transferred to clean wells in a
48-well, clear-bottomed plate and were incubated with 500 pL of TMB substrate. The plates
were immediately placed in a plate reader and the absorbance was measured at 650 nm every
60 seconds for 20 minutes with a vigorous agitation (plate reader setting) between each read
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to move the stainless steel disks to a new location in the well. This was done so that any
blockages of the light beam by the disk would not last for more than one consecutive read.
The slopes of the kinetic data were calculated, after removing any data points where it was
obvious that the stainless steel disk had blocked the light path. Each protein combination
was measured in triplicate and the background absorbance rates were subtracted from each
value.
2.5.8 Calculating binding affinity
Enzymatic rates were plotted against protein/peptide concentrations. Using QTI Plot, the
equation
(Rmax) (x)
y = (2.1)KD + X
was used to fit a sigmoidal curve through the values, to solve for Rmax and KD.
2.5.9 Functionalization of TCT-PS with 2K1-CM15
Tissue culture treated polystyrene wells were incubated with different concentrations of pep-
tides ranging from 200 pM to 3.12 pM in PBST for one hour. Wells were then washed
with PBST three times. E. coli cells (ATCC 25922) were grown overnight from a single
colony and were then rediluted the next morning and were grown to mid-log phage (OD6 00
= 0.4). The cells were then diluted to OD 600 = 0.0035 in fresh LB and were added to the
wells. The plate was placed in a plate reader with shaking and temperature control. The
cells were grown for 4 hours at 370C. During the growth, the absorbance at 600 nm was
measured and recorded on a regular basis. To calculate growth inhibition for each sample
and concentration, the following equation was used:
AbsorbanceT=4 hours - AbsorbanceTo (2.2)Fold growth =bsor2.2e)
Absorbancer.o
The plates were then removed from the shaker, stored overnight at 4'C and were washed the
next morning 2x in IX PBS to remove unbound cells. To measure the inhibition of adhesion
of live cells to the material surface, the wells were stained with LIVE/DEAD (Invitrogen)
cell stain with a final concentration of 2X propodium iodide and 1X Syto 9 in 1X PBS.
Three replicate images were taken in each well and there were two replicate wells for each
peptide and concentration. Images were taken using a green filter (GFP) and a red filter
(PI). The images were processed using ImageJ according to the following protocol. 1) Adjust
brightness and contrast (using auto adjust when possible). 2) Adjust threshold (using auto
adjust when possible). 3) Make a histogram of number of pixels above the threshold (this
counts the area covered in the image by the number of green (live) or red (dead) cells). 4)
Record the number reported in channel 256 (total number of pixels above threshold). The




Engineered yeast for enhanced CO 2
mineralization
3.1 Summary
In this work, a biologically catalyzed CO 2 mineralization process for the capture of CO 2
from point sources was designed, constructed at a laboratory scale, and, using standard
chemical process scale-up protocols, was evaluated at an industrial scale. Engineered Sac-
charomyces cerevisae was used to enhance the hydration of CO 2 and the mineralization rate
of CaCO 3 . The enhanced rates were verified using quantitative techniques in lab-scale mea-
surements. In a variety of different tests, including pH and temperature stability and CO 2
hydration activity, yeast displayed bovine carbonic anhydrase II (bCA2-yeast) performed as
well as soluble bovine carbonic anhydrase II (bCA2), which has a reported turnover rate of
1x10 6 seond. Several possible yeast-displayed mineralization peptides were tested for CaCO3
mineralization rate enhancement. At concentrations below 2x10 12 peptides, there was littlemL
to no effect on the mineralization rate for the yeast-displayed peptides. At concentrations
around 2x10 12 e des, though, there was a roughly 50% increase in mineralization rate,
which appeared to be independent of the peptide sequence displayed. Even the yeast with
no peptide displayed was able to increase the mineralization rate by 20%-30% when tested
at the same cell concentrations as the peptide-displaying yeast.
The effect that these enhanced CO 2 hydration and CaCO 3 mineralization rates have
on the CO 2 capture cost in a CO 2 mineralization process using coal fly ash as the CaO
source was then evaluated. The cost impact of the bCA2-yeast on the process is significant,
decreasing the predicted cost of CO 2 capture by 8.5% to 13.5%, when compared to a CO 2
mineralization process with no biological components. This process model also predicts that
the use of purified soluble, recombinant CA2 would not provide these same cost savings
(only accounting for the difference in production and purification costs and ignoring the
mineralization rate and settling rate effects).
While the total cost of CO 2 capture by this process is still higher than the costs of
other techniques for CO 2 capture, mineralized CO 2 has the advantage of being permanently
sequestered and also of being in a form that lends itself to use in downstream applications
(especially in the building and construction industries).
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3.2 Introduction
3.2.1 Climate change is caused by anthropogenic CO 2 emissions
"Warming of the climate system is unequivocal, as is now evident from obser-
vations of increases in global average air and ocean temperatures, widespread
melting of snow and ice and rising global average sea level."
- Intergovernmental Panel on Climate Change (IPCC)
IPCC Fourth Assessment Report: Climate Change 2007 [49]
Over the last century and a half, atmospheric carbon dioxide (C0 2 ) levels have increased
35% and anthropogenic CO 2 sources are largely responsible for this increase, which is, in
turn, a major contributor to climate change. [50] Though the full impact of continued climate
change is still uncertain, first effects are already evident. According to the IPCC, there is
"high confidence that recent regional changes in temperature have had discernible impacts
on physical and biological systems." [49] The changes are having broad impacts, including
on human health, travel, and recreation, as well as on the suitability of land for residential
development, and agricultural, forestry and fishery management.
There is no simple solution for a problem of this magnitude. The human response to
global warming will require a combination of adapting to a changing planet, altering the
manner and amount of energy consumption, and reducing the release of greenhouse gases
(like C0 2 ) during energy production. The largest energy-related emitters of global CO 2
are the world's 2100 coal-fired power plants. [51] The capture of CO 2 from these sources
motivated this work.
The concentration of greenhouse gases in the earth's atmosphere has progressively in-
creased as the human population has grown, especially since the onset of the Industrial
Revolution in the 1850's. [49]. Atmospheric CO 2 levels have increased from 280 parts per
million (ppm) in the nineteenth century to 380 ppm in 2006. [50] Over the same time period,
the global temperature has increased by 0.6 ± 0.170 C. [49] The increase in CO 2 and other
greenhouse gas levels is widely accepted as the cause of the increase in the average global
temperature. [52] The consensus among climate scientists is that CO 2 levels should not be
allowed to rise above 500 ppm - otherwise the result may be significant and deleterious al-
terations to the global climate. This means that the global community must avoid releasing
175 gigatonnes (Gt) of carbon into the atmosphere in the next 50 years. [50]
Emissions from the world's 2100 coal-fired power plants are responsible for about a third
of the CO 2 released into the atmosphere. [53] Since 2003, coal has been the leading con-
tributor to global energy-related CO 2 emissions. [51] Atmospheric CO 2 released by burning
coal will continue to increase, due to the vast worldwide reserves of coal (almost 150 years'
supply at current usage rates) and the increasing global demand for energy. [54] In fact, the
overall capacity of the world's coal-fired power plants is projected to double by 2030, to 2200
gigawatts. [55] Additionally, the number of all large CO 2 emission sources (electric power
and industrial manufacturing plants) is projected to continue increasing. [52]
To reduce the amount of CO 2 that is released into the atmosphere by anthropogenic
sources, a multi-pronged strategy will be required. This strategy must include more conser-
vation of energy via improved energy efficiency and reduced energy consumption, as well as
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increased use of low- and near-zero carbon energy sources. However, given the vast reserves
of fossil fuels still available and the large global infrastructure in place to create energy from
fossil fuels, it seems very likely that most, if not all, of the fossil fuels will be consumed. [56]
In order to mitigate the global harms, the CO 2 produced during the combustion of fossil
fuels must be captured and stored rather than released into the atmosphere. Carbon cap-
ture and storage (CCS) is most easily applied to the large point sources of CO 2 (those that
emit more than 0.1 megatonne (Mt) per year), such as fossil fuel power plants and industrial
manufacturing plants. [52] This work focuses on capturing CO 2 from these sources.
3.2.2 Carbon capture and storage strategies
Several technologies for transporting and storing large volumes of CO 2 are already beyond
the research stage, as a result of innovations piloted by the mining and energy industries.
Additionally, several CO 2 capture technologies are already mature enough to be considered
economically viable in certain situations. For example, transporting large volumes of liquid
or gaseous CO 2 from a capture point to a storage point via a pipeline could be achieved using
the same technologies that the oil industry already uses to move oil and natural gas. As
part of a process called enhanced oil recovery (EOR), the CO 2 can then be pumped into an
underground oil bed to help extract additional oil while simultaneously geologically storing
the CO 2 .
The existence of mature CO 2 capture and storage technologies should not preclude the
development of additional CCS options. A reduction in anthropogenic CO 2 emissions will
not be achieved with a single strategy and there are significant costs and risks associated
with existing CCS technologies. For example, once the CO 2 has been captured, it must
be transported and stored. If mature CCS technologies are to be relied upon, then the
captured CO 2 will be in a gaseous or liquid form. The two most likely options for storing
it are in deep underground geological formations or in the ocean. Both of these strategies
carry legitimate risks of CO 2 leakage back into the atmosphere and these sites will require
long-term monitoring. [57]
Additional drawbacks to some of the CO 2 storage options are the storage capacity and
the storage time. [57] For example, EOR is only capable of storing tens of Gt of CO 2 - just
barely more than several years' worth at current emissions rates. [57] In contrast to EOR and
other mature CCS technologies, mineral carbonation, one of the least mature technologies,
has a significant storage capacity and long storage time. [57] Mineral carbonation entails the
conversion of CO 2 to solid carbonate minerals like calcium or magnesium carbonate.
CO 2 mineralization is an attractive CCS technology for several reasons. Mineral carbon-
ates are theoretically capable of storing all of the twenty-first century's CO 2 emissions. [57]
Also, it is unlikely that the CO 2 will be released into the atmosphere if it has been mineral-
ized, because carbonate minerals are the most geologically stable form of carbon dioxide -
being stable on the order of thousands of years. [57]
Carbonate minerals have a significantly lower energy state than CO 2 and, at least theoret-
ically, the mineralization process could produce energy. The reactions of CO 2 with calcium
and magnesium oxide generate 179 k- and 118 k, respectively. [58] In context, this is
mole ml
only two to three times less energy than is generated by the combustion of carbon, which
generates 394 k . It is important to clarify that calcium and magnesium are much more
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abundant in mineral form than they are as simple oxides, a topic which any CO 2 mineral-
ization strategy must address. Still, the carbonation reaction is exothermic even for these
minerals, generating energy on the order of 50-100 kj-. [58] Thus, at the very least, the
mineralization reaction could be expected not to consume additional energy. A net energy
requirement of zero is a desirable feature of any CCS technology, since consumption of energy
during CCS equates to an increase in the cost of the energy produced by the power plant.
Another concern with mineral carbonation is that the molar weight of carbonate minerals
is heavier than that of pure CO 2 . A typical (300 MW) coal plant releases 7.0 x 106 kg of
CO 2 into the atmosphere. Capturing this CO 2 in the form of calcium carbonate (CaCO 3 )
would produce 7.0 x 108 kg of CaCO3 , which would then need to be transported and stored.
This is a staggering number. However, the mining and coal industries already function on
this scale. A 300 MW coal plant burns 20% of this mass of coal every day and, thus, a nearly
20% reduction in CO 2 emissions using mineral carbonation could be met without the need
to increase the plant's solids handling capacity. Moreover, the transportation and storage
costs of carbonate minerals must be compared to those of liquid or gaseous C0 2 , which will
be substantial in their own right. If the mineralization process could create a material of
economic value, then the transportation and storage costs might be born by the downstream
user.
Mineral carbonation faces its own challenges for CO 2 sequestration because the min-
eralization process occurs slowly or requires extreme and costly operating conditions. [56]
Some attempts have been made to improve the reaction with high temperature or pressure,
but the use of these reaction pathways leads to cost estimates of $60-100 per tonne of CO 2
sequestered, which is well above the $1-5 range for ocean and geologic sequestration. [58,59]
3.2.3 Biologically catalyzed mineralization as a CCS solution
A biologically catalyzed approach might make mineral carbonation economically feasible by
combining standard temperature and pressure (STP) conditions with the low cost of cell-
surface-anchored enzymes and peptides (as compared to the costly amine-scrubbers and re-
capture processes that are required for other CCS technologies). Fortunately, there are many
examples in nature of biologically catalyzed CO 2 mineralization. The growth of carbonate
minerals in mollusk shells, sea urchin spicules, coral, avian eggshells, and oyster pearls is
controlled and catalyzed by organic biomolecules. [60-64]
The goal of this work, then, was to design, build, model the scale-up of, and evaluate a
biologically catalyzed system that can be used to capture CO 2 directly from the flue gas of
a fossil fuel power plant. This would eliminate the necessity of pre-capturing the CO 2 from
the flue gas, which is typically 15% CO 2 and 85% N2 . Integrating CO 2 capture and mineral
sequestration has been proposed as one way to make mineralization more competitive as a
CCS technology. [58]
Others have investigated biomineralization for CO 2 sequestration. In prior work, bacteria
and cyanobacteria suspected of being capable of biomineralization were screened for the
ability to remove CO 2 from a closed reactor. [65-67] The species that were identified took
several days to have a detectable impact on the CO 2 levels in a small reactor - results that
are promising, but ones that leave biomineralization out of contention as a serious large-scale
CCS option.
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The approach reported here differs in that it entailed starting with a well-known biolog-
ical organism and engineering in the ability to catalyze the mineralization of C0 2 , rather
than testing organisms with known biomineralization abilities. Since CO 2 mineralization
is a multi-step process, this allowed for the determination of which peptides and proteins
participate in the mineralization process and the contribution of each to the overall reaction.
This bottom up approach provided more exact control over the molecular components in
the system, aiding in system optimization. Additionally, knowing the contributions of each
component in the system facilitated the development of a scaled-up process model, which
was used to simulate and evaluate the performance at a large scale.
The mineralization process of CO 2 can be broken down into three steps: the dissolution
of CO 2 into an aqueous solution, the conversion of CO 2 to bicarbonate, and, finally, the
mineralization of the bicarbonate by divalent cations like calcium or magnesium (see Table
3.1). The approach for this work was to address each of the three steps individually. The
first step, the dissolution of CO 2 , can be controlled by modifying the process equipment used
to absorb the CO 2 . The rate of the second step, the conversion of CO 2 to bicarbonate, can
be enhanced by an enzyme, carbonic anhydrase. The hypothesis for this work was that the




CO 2 absorber design0 2 (q) affects dissolution rate
Addition of carbonic1 CO2 +a) H2 0 # HCOI + H+ nyrs(44) anhydrase
2 H+ + HC03 + Ca 2+ + 2OH- CaCO3 + H20 Addition of mineraliza-
tion peptides
Table 3.1: Reactions in the C02 mineralization process Strategies for enhancing the rate of
each reaction are listed in the column next to the reactions. Double arrows indicate that
a reaction is reversible. The single arrow in the last reaction indicates that the reaction is
essentially irreversible under the conditions proposed for this work.
Rather than attempt to utilize existing biomineralization organisms for CO 2 sequestra-
tion, a biomineralization system was engineered from the bottom up. This approach had
two benefits. First, it allowed for the selection of a biological organism that is easy to culti-
vate, well-understood and relatively innocuous. Easy cultivation was desirable because the
scale of the solution will require large amounts of the engineered organism. The objective
also dictates that the organism be well-understood and innocuous. The carbonate mineral
product or the waste materials from each CO2 capture site could contain some of the bio-
logical material used to catalyze the reaction. Given the public's general cautiousness with
new biological technologies, using an unknown organism for the CCS solution might lead to
implementation problems due to (possibly unsubstantiated) safety concerns associated with
the release of the organism.
Second, by choosing to engineer from the bottom up, there was greater control over
the amounts and concentrations of the biomineralization peptides and proteins. This was
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beneficial because the engineered organism needed to catalyze CO 2 mineralization under the
specific reaction conditions defined by the final application - that is, in a industrial-scale
reactor designed to capture CO 2 from the flue gas of a power plant.
With these constraints in mind, the yeast S. cerevisae was chosen. S. cerevisae has been
used in the food and beverage industry for years and has "generally regarded as safe" (GRAS)
status. This addresses two of the requirements established above. First, the protocols for
cultivation and disposal of large quantities of S. cerevisae already exist. Second, utilizing S.
cerevisae minimizes the chances of encountering safety concerns associated with the use a
biological organism.
In addition to being relatively safe and easy to cultivate, there is a convenient and robust
method for engineering S. cerevisae cells to express specific peptides and proteins on their
outer cell walls called "yeast surface display" (see Figure 3.1). [68,69] This method allowed for
the systematic testing of each component of the biomineralization process. In yeast display,
the agal gene is in the yeast genome under the control of a galactose-inducible cassette,
whereas the aga2 gene and the gene for the protein to be displayed (in the image, human
carbonic anhdrase II, or hCA2) are under the control of galactose-inducible cassetteon a
plasmid. Once induced, Aga2 is fused to Agal via disulfide bonds and the hCA2 enzyme is
displayed on the N-terminal end of Aga2.
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Figure 3.1: Cartoon image of yeast-displayed hCA2 The agal gene (red) is in the yeast
genome under the control of a galactose-inducible cassette, whereas the aga2 (purple) and
hCA2 (green) genes are under the control of galactose-inducible cassette on a plasmid. Once
induced, Aga2 is fused to Agal via disulfide bonds and the hCA2 enzyme (in green) is
displayed on the N-terminal end of Aga2.
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3.3 Results
3.3.1 Enhanced conversion of CO 2 to HCO3
The first part of the work was to accelerate the rate of hydration of CO 2 to bicarbonate
(HCO3 ) under the conditions necessary for CO 2 mineralization from the flue gas of a power
plant. The enzyme carbonic anhydrase II (CA2) was selected as the model way of achieving
this acceleration, since it is a well-studied, robust enzyme with high activity (see Table
3.2). In addition, CA2 is a cytosolic isoform, which means that it is compatible with the
yeast-display technique.
Bovine carbonic anhydrase is commercially available in a lyophilized form, so it was used
as a control against which to measure the activity of carbonic anhydrase displayed on the
surface of S. cerevisae cells. Human and bovine carbonic anhydrase II genes were cloned
into the yeast display plasmid as described below. Expression of genes from the pCTCON2
plasmid leads to proteins that are fused to the N-terminal end of the Aga2 protein - a yeast
mating protein that is permanently anchored to the surface of the yeast cell. In addition,
the fusion protein has two epitope tags, an HA tag in between Aga2 and the gene of interest
(carbonic anhydrase, in this case) and a c-MYC tag on the C-terminal end of the gene of
interest. See Figure 3.1 for a cartoon image of the yeast display system. By staining the
yeast cells with fluorescently labeled antibodies against these epitope tags, one can confirm
and quantify expression levels of the fusion protein and the protein of interest.
Initially, two isoforms of carbonic anhydrase II, the bovine (bCA2) and human (hCA2)
were displayed on the surface of S. cerevisae cells. Since maximal expression of the enzymes
is critical to the performance of the CO 2 mineralization process, the expression levels of
the enzymes was measured at several induction time points over the course of three days
of induction. Somewhere between 1 and 1.5 days, the cells reach the maximal average
expression level, which is ~ 100,000 '"'es (see Figure 3.2a). It takes another 12 to 24
cell
hours of induction to reach the maximum numbers of enzymes in the fermentation (Figure
3.2) due to the fact that the cell concentration continues to increase. The important metrics
from these data for the CO 2 capture process design are the average expression levels of CA2
per cell and the amount of time it takes to reach those cell densities.
After verifying that the S. cerevisae yeast display system can be used to express carbonic
anhydrase enzymes on the surface of the cells, the next step was to determine whether the
Isozyme Activity level kcat (s ) Cellular location
hCA I moderate 2.0 x 105 cytosol
hCA II very high 1.4 x 106 cytosol
bCA II very high 1.0 x 106 cytosol
hCA III very low 1.0 x 104  cytosol
hCA VA low 2.9 x 105  mitochondria
hCA VI moderate 3.4 x 105 secreted
hCA IX high 3.8 x 105 transmembrane
Table 3.2: Selected carbonic anhydrase isoforms Human and bovine carbonic anhydrase
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Figure 3.2: Measurement of carbonic anhydrase expression levels at different induction times
(a) This figure shows the average number of enzymes displayed per cell for four different
batches of carbonic anhydrase II expressing cells. (b) For two batches of bCA2-yeast, the
levels of enzyme displayed per cell is plotted in addition to the total amounts of enzyme in the
fermentation. While the average number of enzymes per cell reaches maximal levels sometime
shortly after 1 day of induction, the total numbers of enzymes in the culture continues to

















enzymes were active. To do this, a modified version of the Wilbur-Andersen method was
used. [72] Soluble bovine carbonic anhydrase from Worthington Enzymes was used as a
positive control in the experiments. Using the enzyme expression levels per cell that were
measured previously, the amount of yeast-displayed enzyme added to the reactions could
be determined by measuring the amount of cells added to the reaction. A comparison of
reaction rates for the various yeast-displayed carbonic anhydrase isoforms to the soluble
carbonic anhydrase could be made in order to determine the activity of each yeast-displayed
isoform relative to the commercially available soluble bCA2.
In addition to hCA2 and bCA2, a third isoform of carbonic anhydrase (CAH) from the
mildly thermophilic bacteria Streptococcus thermophilus was displayed on the surface of the
yeast. The hypothesis was that CAH would be more stable at the elevated temperatures
that might be present in the industrial scale CO 2 capture process. This isoform was chosen
because S. thermophilus has a preference for growth at temperatures that are slightly higher
than that preferred by humans and cows (42'C vs. 37 0 C). The use of a carbonic anhydrase
isoform from a more severe thermophile was considered, but those isoforms all appeared to
be y-type with multiple transcriptional subunits combining to form the completed enzyme.
This approach was not expected to be compatible with the yeast-display system in its current
form.
As can be seen in Figure 3.3, all three isoforms were expressed in an active form on the sur-
face of the S. cerevisae cells. Both the bCA2 and CAH isoforms had comparable activity to
the soluble bCA2, whereas the hCA2 appeared to have lower activity. To more quantitatively
assess the activity of the yeast displayed isoforms, a modified version of Wilbur-Andersen
units was used. [72] Briefly, the amount of time that it took for the blank reaction to reach
50% completion was subtracted from the time for the sample reaction to reach 50% and the
result was divided by the sample time to reach 50% completion. An example of these results
for the bCA2-yeast sample are reported in Figure 3.3d, and the same analysis was performed
for the other two isoforms displayed on yeast.
Using this assay, it is not possible to obtain an exact measurement of the turnover rate of
the carbonic anhydrase enzymes displayed on the yeast cells, because the assay is performed
at 4C. This assay is suitable, however, for determining relative activity compared to a
control sample with a known turnover rate. Both the CAH-yeast and the bCA2-yeast had
activities that were comparable or better than the soluble bCA2, so further assessment of
the utility of the yeast-displayed enzyme in a large-scale CO 2 mineralization process was
performed with these two isoforms.
The next step in assessing the utility of yeast-displayed carbonic anhydrase in a CO 2
mineralization process is to measure the stability of the enzymes under conditions to which
they might be exposed in the industrial process. The industrial process is being designed with
a specific CO 2 generation source in mind, and it is onerous to cover every possible condition
that could exist in an industrial CO 2 capture process. However, the most likely source of
degradation for the enzymes is exposure to elevated temperatures in the capture process
(flue gas temperatures often exceed 100 C and proteins are well-known to be susceptible to
degradation at elevated temperatures).
To assess the temperature stability of bCA2-yeast and CAH-yeast, a large batch of each
sample was made and expression levels were measured to determine the amount of enzyme
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Figure 3.3: Activity of yeast displayed carbonic anhydrase isoforms compared to commercially
available bovine carbonic anhydrase (a) hCA2-yeast catalyzed hydration of CO 2 measured
at 40 C (b) CAH-yeast hydration of CO 2 measured at 4C (c) bCA2-yeast hydration of CO 2
measured at 4*C (d) Results of bCA2-yeast titration normalized to the no enzyme sample.
Activity was calculated by the amount of time to reach 50% reaction completion. Each
concentration was measured in duplicate and values are reported as averages with 1 standard
deviation error bars.
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pH 8.8 and were split into aliquots that were stored at 50 0C or at 4*C. The samples were
returned to 4'C to measure the activity. The starting activity levels of each was measured
using a modified version of Wilbur-Andersen units (see Section 3.5.6 wherein each sample's
activity in Wilbur-Andersen units are reported per nmole of enzyme in each reaction). By
converting the results of the activity assay into activity units per numbers of enzyme, the
dynamic range of the assay can be extended and samples of varying concentrations (or
varying activities) can be compared to each other. The results of the 50*C stability study
are reported in Figure 3.4a. An examination of these results shows that the bCA2-yeast and
the CAH-yeast had roughly the same starting activity (which was about 4 times higher than
that of the soluble bCA2). It is unlikely that the yeast-displayed enzymes are really more
active than pure bCA2. This difference could be due to a slight loss of activity in the bCA2
sample from the preparation, shipping, or storage conditions of the soluble bCA2 (purified
from bovine erythrocytes, lyophilized and shipped from Worthington Enzymes and stored
in a -20*C freezer in lab).
(a) (b)
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Figure 3.4: Temperature and pH stability of yeast displayed carbonic anhydrase isoforms
(a) Modified Wilbur-Andersen units (amount of time for reaction to reach 50% completion
compared to blank reaction) per nM are reported for each enzyme sample. Day 0 samples
are freshly prepared enzyme solutions. The samples were stored at 50'C for 3 days and 7
days and activity was measured for each sample using the assay described in Section 3.5.5.
(b) The results for each sample were normalized to the starting activity levels so that the
stability of each sample could be compared to that of the other samples. bCA2-yeast and
bCA2 in solution both retain more than 20% of their original activity even after 3 days at
50oC.
In order to compare the temperature stabilities of the yeast-displayed carbonic anhydrase
isoforms to each other and to the soluble bCA2 more easily, the results from Figure 3.4a
were normalized to the Day 0 activity levels for each sample (e.g., "" ). These results
(reported in Figure 3.4b) show that the bCA2 in solution and bCA2-yeast have very similar
temperature stability profiles. Even after three days at 50*C, they retain more than 20%
of their original activity, and after seven days at 50*C, they retain more than 10% of their
original activity. Interestingly, the carbonic anhydrase isoform from the thermophilic S.
thermophilus did not have superior stability compared to bCA2 at 50'C. For this reason,
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the use of CAH-yeast was not further pursued in this work.
Finally, the pH stability at pH 7.0, pH 6.0, pH 5.0, and pH 3.0 of the bCA2-yeast
was calculated and compared to soluble bCA2, using the same assay as that used for the
temperature stability. The samples were stored for sixteen hours in the different buffered
solutions, then were rinsed and resuspended into (for bCA2-yeast) or diluted into (for bCA2
in solution) the assay buffer. The activity was measured at 4C and the result was normalized
to the activity of freshly prepared sample. The bCA2-yeast and the bCA2 in solution have
comparable stabilities, with both retaining more than 60% of the original activity down to
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Figure 3.5: pH stability of bCA2-yeast and bCA2 in solution Samples were stored for 16
hours at 4C from pH 7.0 to pH 3.0. Samples were then transferred to the CA2 assay buffer,
activity was measured and compared to the starting activity.
These results demonstrated that bCA2 displayed on the surface of yeast cells has com-
parable activity to soluble bCA2. The reported turnover rate of bCA2 is 1 x 106 1 (see
Table 3.2). A conservative turnover rate of 6 x 105 ,1con was chosen for the value to be used
in the scaled-up process design (see Section 3.3.7) to account for unforseen process effects
that might decrease the efficiency of bCA2-yeast.
3.3.2 Enhanced mineralization of CaCO3
The second part of this work was to identify biomolecules displayed on the yeast S. cerevisae
that could accelerate the mineralization rate of CaCO3 . To do this, a mineralization assay
that could measure the kinetics of mineralization had to be developed. Figure 3.6 shows a
cartoon image and a photo of this assay configuration. Briefly, a calcium-sensitive electrode
was used to measure the rate of decrease of Ca2 + ions in a solution as sodium bicarbon-
ate was added. As the bicarbonate and calcium ions combined to form calcium carbonate
crystals (releasing a hydrogen ion in the process), the concentration of Ca2 + decreased. The
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rate of addition of the bicarbonate solution was set to be faster than the expected rate of
mineralization, so as not to be rate-limiting. The change in Ca2+ concentration was recorded
via an attached computer and the slope was converted to moles CaCO 3 formed per second,










Figure 3.6: Mineralization rate measurement A beaker (or 50 mL Falcon tube) with a mag-
netic stir bar was set on top of a stir plate. The beaker was filled with a solution of Ca 2+ ions
(with chloride as the counter ion) and the peptide displaying yeast samples. A calibrated
calcium sensitive electrode was placed in the solution. A syringe pump was used to inject, at
a consistent rate, a solution of HCO3 1 ions (with sodium as the counter ion) into the beaker.
The temperature of the solution was verified to be 25*C. The electrode was connected to
an ISE meter and the data was pulled into a spreadsheet on an attached computer via the
RS232 port. (Inset: A photo of the mineralization rate measurement system on the lab
bench.)
There are several natural examples of biologically catalyzed mineralization of carbonate.
[60-64] The mineralized tissues of many organisms have been analyzed and found to contain
peptides rich in acidic amino acids and phosphorylated amino acids, though they occasionally
also contain acidic sulfated polysaccharides or glycoproteins. [73]
With respect to the mineralization of calcium carbonate, the acidic peptides appear
to interact electrostatically with calcium in order to initiate the nucleation and, in some
circumstances, to control the growth of the mineral. These peptides are rich in aspartate
and, to a lesser degree, glutamate, and they often appear in repeated motifs. For example, in
the scallop shell protein MSP-1, the aspartate residues are arranged "more or less regularly
... exhibiting some repeated motifs such as Asp-Gly-Ser-Asp and Asp-Ser-Asp ... . [These]
domains indicate remarkable overall sequence similarities to each other. These observations
suggest that the regular arrangements of COO- groups" are important for the growth of
calcium carbonate. [74] In the protein nacrein, which assists in the mineralization of calcium
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previously. All of the peptides were displayed at high levels on the surfaces of the S. cerevisae
cells 100,000 peptides . The total number of peptides per 2 x 107 cells that was used in the
cell clsta 
mineralization assay was calculated and is reported in Table 3.3. Each yeast-peptide strain
and a non-expressing strain of yeast was then tested in the mineralization assay at two
concentrations: 2 x 108 ells and 2 x 107 cells (1 OD6 oo and 10 OD600 , respectively). Them L m7 L
results are shown in Figure 3.7. At 2 x 107 cells, there is little effect on the mineralization
cellsmL'
rate, but at 2 x 108 cls some of the yeast-displayed peptides increase the mineralization rate
50% or more. GPA, (D 3 G)6 , (D 3 S) 6 , and FLK have the greatest effect on the mineralization
rate, though these are also the peptides that are expressed at the highest concentrations.
The cells that are not displaying any peptide also increase the mineralization rate of
CaCO 3 and there is a dose-dependent response (i.e., more yeast cells leads to faster min-
eralization). This is not surprising given that S. cerevisae cells are covered in negatively
charged biomolecules and it has been previously reported that CaCO 3 can be mineralized on
the surface of S. cerevisae cells. [78] Note that the majority of the peptide-yeast strains that
are expressing negatively charged peptide do not have significantly higher mineralization
rates than the yeast cell with no peptide. One explanation for this phenomenon could be
that the Agal-Aga2 fusion protein that is expressed with every mineralization peptide could
be large enough to be sterically blocking the growth of CaCO3 crystals on the negatively
charged native surface of the S. cerevisae cells. And only once the peptide concentration
reaches a minimum level (~zz 1 x 1013 pepudes) does the presence of the mineralization peptide
overcome this effect.
The important parameters that are necessary for the development of a large-scale CO 2
mineralization process are what concentration of cells to use and what the mineralization
rate will be for the system in the presence of those cells. Thus, two possible scenarios were
evaluated for the large-scale process. The first scenario was one in which just one strain of
yeast (the bCA2-yeast) would be used to catalyze the hydration of CO 2 and also to serve as
a mineralization template (with the assumption that the mineralization rate would be on the
lower end of the peptide-yeast sample mineralization rates ~ 6.3 x 10- 4 m" ). The second
would be to have two strains of yeast, bCA2-yeast to catalyze the hydration of CO 2 and then
a second strain to promote the mineralization of CaCO3 . The second strain was proposed
to be GPA-yeast at a concentration of 2 x 10 cells, which increased the mineralization rate
to 9.3 x 0-4 moles mL
(L)(sec)*
3.3.3 CaCO3 is mineralized on the surface of the yeast cells
The formation of CaCO3 on the surface of the N66-yeast cells was verified by analyzing
the cells with a light microscope. The samples were prepared as described in the exper-
imental section. Representative images from the light microscope with and without the
cross-polarization filters in place are shown in Figure 3.8a and b. It is apparent that the
crystals are bound to the surface of the cells and that they are capable of changing the polar-
ization of light (since only the objects that are "attached" to the cell surface are illuminated
in the cross-polarization microscopy (CPM) images).
The bulk sample from the N66-yeast mineralization reaction was then analyzed by x-ray
diffraction (XRD) to determine what type and morphology of crystal was being formed.
The XRD analysis confirmed that CaCO 3 was the only crystal being formed. The resulting
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Figure 3.7: Measurement of mineralization rate enhancement by yeast displayed peptides (a)
The mineralization rate of CaCO3 in the mineralization reactor was measured for each of
the ten strains of peptide-expressing yeast, as well as for a no peptide strain of yeast, at
two concentrations of cells 2 x 108 -, and 2 x 107 f. The baseline mineralization rate
was measured without yeast in the mineralization reactor. Each sample was measured in
duplicate and the averages are reported. Error bars represent one standard deviation. (b)
The mineralization rates for each sample were normalized to the rate of the blank (no yeast)
sample and are plotted against the concentration of peptide in the sample. The yeast with
no peptide is plotted at an arbitrary concentration of 1 x 1011 **f"/~E so that it can be viewed
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Figure 3.8: Cross-polarized microscopy and X-ray diffraction confirmation of CaCO3 min-
eralization (a) Representative image of the N66-yeast from the mineralization reactor. The
dark objects that are attached to the yeast cells are CaCO 3 . For scale, the average yeast cell
is 5 pm in diameter. (b) Cross-polarized microscopy image of the same sample from (a). In
this image, only objects that can change the polarization of light (i.e., CaCO3 crystals) are
illuminated (c) XRD chromatogram confirms that calcite is mineralized in the presence of
N66-yeast.
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chromatogram is in Figure 3.8c. Moreover, the peaks in the XRD chromatogram match the
peaks from the calcite reference card, with no discernible matching to vaterite or aragonite
reference cards (not shown).
XRD analysis was performed on a mineralization reaction with 10X lower concentrations
of CaCl2 and NaHCO 3 (10 mM instead of 100 mM) using the "no peptide on yeast" sample
and the presence of calcite only was confirmed. Interestingly, under those same mineraliza-
tion conditions, if there was no yeast present in the reaction, the CaCO 3 was composed of
calcite and vaterite (data not shown). This result is consistent with the well-established role
of biomolecules in the stabilization of specific crystal structures in biomineralization. [61]
Using these methods, it was not possible to confirm absolutely whether the nucleation was
occurring on the yeast cells, or whether it was occurring in solution and then the peptides
were binding the nascent crystals. However, the evidence suggests that it is the former,
rather than the latter that is occurring, especially in light of the XRD data from the yeast
and the no yeast mineralization reactions. Either way, the critical focus of this project was
the rates and the costs of mineralization, rather than the mechanism.
3.3.4 Development of a lab-scale CO 2 mineralization reactor
The next step of this work was to verify that the engineered yeast could be used to enhance
the rate of the entire process (i.e., the couple reactions of gaseous CO 2 to mineralized CaCO3 ).
To do this, a lab-scale CO 2 mineralization reactor was designed and built. This reactor was
composed of a standard glass laboratory bottle (the volume of the bottle was dependent on
the volume of the reaction) with a threaded cap. A custom-made stainless steel cap for the
bottle was made that fit the threading on the bottle and that had three ports in the top.
Two of the ports accommodated stainless steel tubing that could slide into and out of the
port (to adjust the delivery height of the mock flue gas and the capture height of the off gas).
Each port had a compression-tightened o-ring to ensure an airtight seal when the stainless
steel tubing was in place. The third port accommodated the Ca 2+-sensitive electrode. This
electrode could slide in and out of the port to adjust the detection height. The port had a
compression-tightened o-ring to ensure an airtight seal once the electrode was in place. The
metal to glass connection between the cap and the bottle was not airtight, and so petroleum
jelly was applied to the threads every time the cap was put in place. The result of this set-up
was that all of the flue gas that was delivered to the reactor was collected by the off-gas port
and was analyzed by the in-line CO 2 detector.
The temperature of the reactor was controlled using a temperature-controlled stir plate,
wherein the thermocouple was placed into a solution of water surrounding the CO 2 reac-
tor. The temperature of the liquid inside the reactor was thus controllable from 250 C-
60'C ± 2'C and was verified to stay at the set temperature for at least 20 hours.
The mock flue gas was a custom-made mixture of 15% CO 2 and 85% N2 . The flow rate of
the gas was controlled by an Alicat Scientific mass flow controller that was calibrated for that
gas mixture. The % CO 2 in the off-gas was measured using an Alpha Omega Instruments
9510 analyzer with a built-in temperature controller to keep the temperature in the detector
higher than the temperature in the reactor (so that condensation of water vapor would not
occur in the detector).
For each reaction, the reactor was filled with the appropriate Ca2+ source, OH- source,
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and yeast strain, the cap was placed on the bottle, and the system was purged with 100%
N2 . The signals from both the Ca 2+-sensitive electrode and the CO 2 detector were recorded
using an attached computer. At time, t = 0, a solenoid valve was used to switch the gas
source from the N2 to the 15% CO 2.
3.3.5 Mineralization in the CO2 capture reactor
The lab-scale CO 2 reactor was then used to test the effectiveness of the engineered S. cere-
visae cells in enhancing the mineralization rate of CaCO 3 using a mock flue gas as the starting
source of carbon. For these experiments, three conditions were tested: 1) no biomolecules in
the reactor; 2) soluble bCA2 in the reactor; and 3) bCA2-yeast in the reactor. The results of
these experiments are shown in Figure 3.9 and are summarized in Table 3.4. Note that the
bCA2-yeast and the soluble bCA2 are both added in excess of the expected required amount
so as to not be rate-limiting in the reaction. Both the bCA2-yeast and the soluble bCA2
enhance the mineralization rate of CaCO 3 in the reactor by 20%-30% (see Table 3.4). The
rates that are reported from this reaction are roughly one order of magnitude slower than
those measured in the mineralization rate experiments from Section 3.3.2. This discrepancy
is likely due to the fact that the absorption of the gaseous CO 2 in the mineralization reactor
is limiting the amount of substrate available for mineralization, which would be avoided in
the scaled-up process by the use of a more efficient absorption column.
Concentration . .2 TmearSample (nM) Mineralization rate () Temperature
No carbonic 0 1.07x10-5 + 4.12x10-7 (S.E.) 25
anhydrase
soluble 67 1.45x10- 5 ± 4.12x10- 7 (S.E.) 25bCA2II
bCA2-yeast 67 1.35x10- 5 + 4.12x10- 7 (S.E.) 25
Table 3.4: Conversion of gaseous C02 to CaCO3 in C02 capture reactor The bCA2-yeast
and the soluble bCA2 are both added in excess of the expected required amount so as to
not be rate-limiting in the reaction. Both the bCA2-yeast and the soluble bCA2 enhance
the mineralization rate of CaCO 3 in the reactor by 20%-30%.
3.3.6 Analysis of cation and alkalinity sources
The aqueous mineralization of CO 2 requires two material inputs. The first is a divalent
cation such as calcium or magnesium and the second is a source of alkalinity (see Table 3.1
and Figure 3.9). There are several possible sources of alkalinity, including reactive mineral
deposits, industrial byproducts (such as coal fly ash or paper mill ash), electrochemically
generated alkalinity from brines or seawater, or non-reactive mineral deposits. A full review
of these sources has been discussed elsewhere. [79-81] To summarize these results, however, it
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Figure 3.9: Lab-scale C02 capture reactor (a) A lab-scale CO 2 capture reactor was built that
was used to measure the effectiveness of the engineered S. cerevisae cells in enhancing the
mineralization rate of CO 2 from a mock flue gas. A Ca 2+-sensitive electrode was used to
monitor Ca 2+concentration in the reactor and an in-line CO 2 detector was used to measure
the CO 2 concentration in the off-gas. (b) The results of a mineralization reaction with real-
time monitoring of the Ca 2+concentration and the CO 2 concentration in the off-gas for no
enzyme and a soluble bCA2 solution (67 nM bCA2). The measured mineralization rates are
reported in Table 3.4
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of the global CO 2 emissions. The first of these is injection of CO 2 into underground reservoirs
that contain the necessary cations and alkalinity. Another is to produce alkalinity through
electrochemical weathering of water, to neutralize the acid generated as part of the process
with mineral sources of alkalinity (using non-reactive mineral sources like serpentinite), and
then to use the hydroxide to neutralize the acid generated by the CO 2 mineralization process.
[80] This is the approach that is being pursued by the company Calera. [81]
While the electrochemical production of alkalinity allows for the capture of CO 2 on a
global scale, a concern with this approach is that it adds additional energy demand to the
CO 2 capture process, thus increasing the cost of the process. Since process cost is a primary
metric for the approach that was designed and evaluated in this work, it was decided to use
a less expensive source of alkalinity - alkaline industrial byproducts like fly ash or paper mill
ash, even though this means that it must be implemented on a smaller scale.
It was estimated that the fly ash produced from a single 200 megawatt coal fired power
plant is approximately 40 ktonne. Assuming a calcium oxide content of 17% by weight, thisyear
amount of fly ash could sequester about 6.5 konn, of CO 2 , or roughly 0.5% of the CO 2year
generated by the power plant. Of course, more of the CO 2 generated by that power plant
could be mineralized if other CaO sources were utilized, but that would require the transport
of those materials to the power plant, which would add additional cost to the process. Thus,
in order to identify the cost feasibility of the most simple process as designed, fly ash from
the power plant is used as the source for both the divalent cations and the alkalinity.
3.3.7 Development of an industrial-scale process model for CO 2
mineralization
Using the results from the laboratory scale experiments, an industrial scale process was de-
signed and evaluated for biologically catalyzed CO 2 mineralization. The mineralization rates
and the CO 2 hydration rate parameters that were used for the dimensioning of the mineral-
ization reactor and the CO 2 absorption column were taken from the lab-scale measurements
and are summarized in Table 3.5. In order to compare the effects of various process param-
eters, a base case was designed and the cost of the process was determined including full
capital equipment, associate labor, maintenance, etc. The annual cost of the process was
then divided by the annual CO 2 capture capacity or the annual solids production (CaCO3
plus other solids, including yeast and inactive materials in the CaO source). These values
allowed for the comparison of different processes in terms of dollars per unit of CO 2 captures
or dollars per unit of material produced.
The following assumptions were made in order to develop the base-case pro-
cess model:
1. CO 2 flux = 6.7 kto"nes * 95% (capacity factor) = 5.09 moles c02year second
2. The flue gas has a rate of 3000 (N) 3 )hour
3. The flue gas has a composition, in percent volume of N2 = 73.8, 02= 3.4, CO 2 = 13.7,
H2 0 = 9.1 and it comes from the flue stack at a temperature of about 85'C and at
atmospheric pressure.
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Reaction Catalyzed Uncatalyzed rate Enhanced rate
by parameter parameter
CO2(aq) + H20 - HCO + H+ bCA2-yeast 0.045 1 [82) 6x10
5  1 [a]
3_______ second_______ second
Reaction Catalyzed Uncatalyzed min- Enhanced miner-
by eralization rate alization rate
2 H+ + HCOs + Ca2 ++ 20H - GPA-yeast 5.2x10~4 m cac [bi 9.3x10- 4 moles CaCO3CC 3 12 (L) (second) (L)(second)CaC03 + H20
No peptide 5.2x10- 4 moles CaCO3 [b] 6.3x10-4 moles CaCo3 [b](L)(second) (L)(second)
yeast
a Conservative estimate based on activity level comparisons to soluble bCA2.
b From Table 3.7.
Table 3.5: CO2 mineralization reactions and associated rates. Reactions in the CO 2 min-
eralization process with the biological catalysts for each reaction and the uncatalyzed and
catalyzed reaction rates measured in the lab. The single arrow in reactions indicates that
the reaction are treated as irreversible under the conditions proposed for this work.
4. A heat exchanger cools the flue gas to 40 'C to reach the optimal temperature for
enzyme stability and a fan blows it into the absorber.
5. Coal fly ash is used as the source of CaO.
6. The calcium oxide has an 85% efficiency of CO 2 capture.
7. The fly ash has a composition, in weight percent of SiO 2 = 50, A12 0 3 = 25, Fe2O 3 = 8,
CaO = 17, which corresponds to class C fly ash.
8. The rate of fly ash addition to the process is roughly 5/ .
9. Only one strain of yeast is to be used: bCA2-yeast, with a CO 2 hydration rate param-
eter of 6 x 105  1 and a CaCO3 mineralization rate of 6.3 x 10- 4 moles CaCO3second (L)(second)
10. The concentration of the bCA2-yeast will be ~ 1.1 x 10' cells in the reactions.mL
11. Water is added to the system such that the slurry in the absorption column is main-
tained at a concentration of 7.5% (by weight) solids. The water will have to be added
to compensate for evaporation in the absorption column and to compensate for the
liquid that exits the process with the solids at the end.
12. The water exiting the process at the end is 15% by weight.
13. Water is added at a rate of 2.5 ,nn's with a circulating rate of roughly 70 tonnes
14. After mineralization, there are two solid separation stages: the first is a gravity settling
stage that leads to a solid content of 25% (from 8%) and the second is a press filtration
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stage that leads to a solid content of up to 85%. Two filter presses are utilized,
working in alternate operation. Finally, a dryer is used to increase the solids content
up to 95.5%.
15. The bCA2-yeast are not separated from the solids (because the calcium carbonate
mineralizes on them), but the water from the settling stage and the filter press stage
can be recirculated and re-used. The water from the gravity settling stage is cooled
to 35'C before being recirculated to the absorber to prevent overheating of the bCA2-
yeast.
16. The spray column absorber allows for a gas flow rate of ;:t 2 ,eid with a pressure drop
of just a few millibars. The diameter of the spray column (1.2 m) is determined by
the speed of the gas flow inside, which is set to a standard rate of 0.75 ,emn. With
a liquid hold-up of 5%, a slurry concentration of 7.5%, and a concentration of 1.1 x
10" cells101L , a 10 m column can absorb the CO2 at the assumed CO2 flux.
5 hassed
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Figure 3.10: Process diagram for biologically catalyzed mineralization of CO2 using fly ash







3.3.8 Impact of carbonic anhydrase on absorber column size
Reaction 2 in Table 3.5 can be thought of as a enzymatic reaction, and the Michaelis-Menten
rate law can be applied to this reaction. By making a quasi-steady-state approximation for
the concentration of enzyme-substrate complex, assuming that the enzyme is not in great
excess over substrate ([E] ? nM, [S] e mM), and assuming that [S] [S]o (since new substrate
is constantly added), the following equation can be derived:
catalyze max S] (3.1)Vcaalyed Km + [S]
where Vmax = (kcat) (moles enzyme) is the maximum reaction velocity, Km = 8 mM, kcat = 6
x105 s and [S] = solubility of CO 2 at 40'C = 22 mM. [83,84] The desired vcatalyzed is
the same as the CO 2 flux = 5.09 moles Co 2 A rearrangement of equation 3.1 allows one to
solve for the moles of enzyme needed to catalyze the reaction in the absorber.
Moles enzyme = (Vcatalyzed)(Km + [S]) (3.2)[S] (kcat)
This leads to a value of 1.16 x 10- 5 moles of enzyme. Next, to determine the volume of the
reactor, the concentration of enzyme in the reactor must determined. It was assumed that
it was best to work at as high of a concentration of bCA2-yeast as possible, to minimize the
reactor volume and the associated captial equipment cost. The assays performed in earlier
experiments (e.g., Figures 3.3, 3.4, 3.7) routinely used concentrations of yeast between 2
x 106 and 2 x 108 1V - Thus, a concentration of cells on the high end of this range was
selected: 1.1 x 108  e 8 OD60 0 ). At this concentration, the yeast solution still behaves
like a liquid, but the amount of bCA2 is high enough to have an impact on the process.
Assuming 100,000 enzymes per cell, this means that the final concentration of enzyme will
be around 27 nM.
The volume of the reactor then can be calculated:
moles enzyme
reactor =concentration enzyme
which leads to a catalyzed reaction liquid volume of 420 L. This liquid volume necessitates
an absorber reactor volume of 1130 L (see Table 3.6).
It is worthwhile to perform the same calculation for the uncatalyzed reaction, to de-
termine the impact that the enzyme has on the reactor volume. To do this, the following
equation is used:
Vuncat = ki[ S] (3.4)
Using the uncatalyzed reaction rate parameter value of 0.045 i for ki, [82] and a value
for [S] that is equal to the solubility of CO 2 at 40'C = 0.022 moles per L, [84] gives an
uncatalyzed reaction rate of 0.001 mole) . Dividing the CO 2 flux by the uncatalyzed reaction
rate gives a required liquid volume of 5090 L, more than 10 times the volume required if
using the carbonic anhydrase yeast.
68
3.3.9 Impact of mineralization rate on mineralization reactor
The calculations to determine the size of the mineralization reactor are based on the miner-
alization rate of CaCO 3 and and the amount of CO 2 to be mineralized. The volume of the
reactor can be calculated using equation 3.5
VOlreactor CO 2 capture rate (35)
ratemineralization
where CO 2 capture rate = (CO 2 flux)(C0 2 capture efficiency of CaO) = 4.33 moles and
ratemineralization is the baseline rate measured in the laboratory experiments for yeast with
no mineralization peptide = 6.3 x 10-4 moles CaCO3 Substituting these values into equationWL)(second)'
3.5 gives an estimated mineralization reaction volume of - 6900 L. If the mineralization
rate could be increased by 3x, the reactor volume could be reduced to - 2300 L, and if
the mineralization rate could be increased by 10x, then the mineralization reactor could
be eliminated and the reaction could occur in the bottom of the absorption reactor. It is
interesting to note, though, that the mineralization part of the process does not have a
significant impact on the process cost (see Figure 3.8). It is also worth considering what
the mineralization rate would be in the absence of the mineralization template provided by
the yeast cells. To do this, the uncatalyzed mineralization rate from the mineralization rate
measurement experiments was used = 5.2 x 10- 4 molesCO (see Table 3.5 and Figure 3.7).(L)(second)(seTbe35adFgr3.)
Substituting this value into equation 3.5 gives an estimated reaction volume of a 8300 L or
20% larger than the catalyzed reactor volume.
3.3.10 Impact of yeast cells on settling reactor
The presence of yeast cells in the mineralization reactor results in much larger particles than
when the CO 2 is mineralized without the yeast cells (see Figure 3.11). Dozens or hundreds
of yeast cells interconnect with dozens or hundreds of calcium carbonate crystals (see the
top image in Figure 3.11) whereas the carbonate minerals formed in the absence of yeast
cells stay as individual crystals (see the bottom image in Figure 3.11). The average particle
sizes for the two conditions were estimated to be 1 mm for the yeast-CaCO 3 particles and
25 pm for the individual CaCO3 particles.
While theoretical ways of predicting settling time exist, they are difficult to apply to
complex materials of irregular shape, and it is best to measure settling times empirically.
The settling time was measured in the lab-scale mineralization reactor by turning off the
stirring and then monitoring the amount of time that it took for the materials to settle
to the bottom of the reactor. The GPA-yeast in Figure 3.11 settled a distance of 7 cm
in approximately 30 seconds (settling time = 14 ') whereas the no yeast sample took
more than 4 hours to fully settle (settling time < 0.029 ) which leads to settling rate
enhancement of almost five hundred fold. Even if it is assumed that the inactive materials
in the fly ash are able to increase the settling rate of the CaCO 3 in the settling reactor by a
factor of 100 (to ~~ 0.3 "), the difference is still almost fifty fold. This is not an unreasonable
assumption, since the particle sizes in fly ash are < 100 pm. This slower settling rate could
have a significant impact on the residence time in the settling reactor (and thus the total





Figure 3.11: Size of calcium carbonate particles mineralized in the presence and absence of
engineered yeast cells (a) This image shows the typical particle sizes of the yeast-CaCO3
particles when CO2 is mineralized in the presence of GPA-yeast cells with a final concentra-
tion of 6 x 1011 PePtid* or 2 x 107 *". (b) This image shows the typical particle sizes of
the CaCO3 particles when CO 2 is mineralized without yeast cells. Both reactions took place
in the CO2 capture reactor described in Figure 3.9 with a starting concentration of 0.1 M
Tris-base and 0.1 M CaCl2 and with a flow rate of 0.1 L of 15% Co 2.minute
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The height of the settling reactor in the base case is 15 m, which would require a settling
time of ~~ 110 minutes. If the settling rate is five times slower, then four additional settling
tanks, staggered, but running parallel would be required to keep the process running. This
would add roughly 2% to the cost per unit of CO 2 captured to the base case.
3.3.11 Production of yeast
In order to determine the amount of bCA2-yeast required for the procees, the following
equation is used:
bCA2 - yeast cells kg DCW
yeast flux = (Volum. rateabsor.)( L )(MWces) 7.5hour (3.6)
where the volumetric rate in the absorber is ~ 6.98 x 104 L , the concentration of cells in
the absorber 1.1 x 108 " from subsection 3.3.8, and the molecular weight of the cells is 1 x
10-12 g DcW The bCA2-yeast are grown in fermenters with an assumed yield of 50% dry cell
weight yeast per gram of sugar (glucose) and with an assumed growth rate of 0.05 kg DOW(L) (day)
The calculated yeast fermentor volume is thus 4.5 m3
There are several assumptions underlying the calculations in this section, which are worth
a brief discussion. These assumptions deal with some technical nuances relevant to the use of
the yeast-display system. The yeast-display system implemented in this work uses plasmid
(i.e., non-genomic) DNA to host the Aga2 and carbonic anhydrase genes, while the Agal gene
is chromosomally integrated. The plasmid is retained in successive generations of cells with
auxotrophic pressure. Expression of the Agal and Aga2-CA2 genes is under the control of a
galactose inducible expression cassette. In practice, this means that minimal media must be
used to retain the plasmid. Even with this selection pressure, however, only 40%-60% of the
cells in a population retain the plasmid, presumably because the missing nutrient is secreted
into the media at a sufficient concentration by the cells with the plasmid so as to support
the cells without it. In the implementation proposed for the final process, however, the
Aga2-CA2 gene could also be genomically integrated, thus avoiding the problems associated
with the use of the plasmid DNA. [85]
3.3.12 Comparison of alternative sources of CA2
There are alternative ways to procure a suitable quantity of carbonic anhydrase to catalyze
the CO 2 to HCO3 reaction in this process and it is thus important to compare the costs of
those approaches to the cost of the approach proposed in this work. The amount of carbonic
anhydrase that is required can be calculated using the following equation:
cells CA2 mole grams CA2 gCA2 flux = (Volum. rateabsor.)( )( )( )( ) 38 (3.7)
L cell CA2 mole hour
where the volumetric rate in the absorber is ~ 6.98 x 104 hr, the concentration of cells in
the absorber 1.1 x 108 cL from subsection 3.3.8, the number of enzymes per cell is 100,000
(see Figure 3.2), and the molecular weight of CA2 = 30 kDa.
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The bCA2 that was used during the development of this process was purified from bovine
red blood cells and is available for purchase at a cost of - $1.25 !. Assuming that economiesmg
of scale could lower this cost by 10OX (and ignoring the number of cows that would need to
be regularly bled to provide 38 grams of enzyme per hour), this would still result in over $4
million per year.
Another way to produce the necessary amount of enzyme would be to recombinantly
produce CA2 in E. coli. [86] A previous report describes a process for the recombinant
production and purification of 3 k9 of heparinase in E. coli for a cost of ~ $1.5 million. [87]year
Assuming that this process could produce 1OOX the amount of carbonic anhydrase as it could
heparinase without an increase in the capital equipment costs (300 kg vs. 3 kg per year),
then the direct effect of the capital equipment costs for the E. coli CA2 vs. the bCA2-yeast
can be made by substituting the equipment costs from the E. coli process for the equipment
costs for the S. cerevisae process. The equipment list and associated costs (in 1998 dollars)
were placed into the capital equipment costs spreadsheet for the CO 2 biofixation process,
which resulted in an increase of 13.8% in the CO 2 capture cost compared to the bCA2-yeast.
The resulting CO 2 capture costs are reported in Table 3.8.
3.3.13 Evaluation of process costs for base case and alternatives
The ultimate goal of this work is to determine the cost to capture C0 2 , and to determine the
cost to produce CaCO3 for downstream applications. Using the process designed in Figure
3.10 as the base case, Aspen Process Economic Analyzer V7.2.1 was used to determine the
capital equipment costs. For special items not listed in Aspen Process Economic Analyzer,
quotes were requested from suitable vendors. The purchase costs of the necessary equipment
for the base case are listed in Table 3.6. Additional infrastructure and set-up costs (including
piping, steel, instrumentation, electrical, insulation, paint, and installation labor) were added
to determine the direct costs associated with this process. Indirect costs, such as general
and overhead costs, engineering costs, contract fees and contigencies were included in the
final cost. Finally, an additional 20% of the total direct and indirect costs was added for
the integration of this process into an existing power plants infrastructure, which brings the
total capital cost to $9.04 million.
The operating costs were calculated based on the amount of electrical energy, the cooling
water, the well cooling water, air, and glucose necessary to operate the process. The oper-
ating costs are reported in Table 3.7. It was estimated that four additional workers would
be needed to operate the system, that annual maintenance would be 3% of the capital costs,
and that an additional 25% of labor and maintenance costs would be required for indirect
costs. The capital equipment costs for a plant depreciation of 15 years and a conservative
estimate of return on capital employed of 9% were calculated. The costs per tonne of CO 2
captured and per tonne of CaCO 3 were then calculated by adding all of these costs. For
the base case, the vast majority of the capture costs are due to the cost of capital (almost
65%), while maintenance and labor contribute 14% and 12%, respectively. Indirect costs
and operating expenses are 7% and 2%, respectively. The results are reported in Table 3.8.
Several parameters in the process were varied in order to evaluate the impact that those
parameters would have on the final costs.
To see what effect an enhanced mineralization rate would have on the process costs,
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Purcase ostDirect cost
Item ID Equipment Size Purchase cost (thousand
(thousand $) (tosn
SO Fermenter 3.83 m3  48 157
Si Fly ash storage 884 m3  188 275
S2 Slurry tank 28.3 m3  89 203
S3 Absorber 11.3 m3  31 164
S4 Mineralization reactor 17.7 m3  58 161
S5 Product storage 180 m3  0 166
S6 Glucose storage 5 m3  36 224
M1 Fly ash feeder (conveyer belt) 81.7 ton 45 128
M2 Settling reactor 577 m3  86 276
M6 Glucose feeder (rotary feeder) 25 kg 4 7
PO Yeast pump 0.1 L 6 25
_________ ______________________________second ______
P1 Circulation pump 7 ,Lnd 7 39
P2 Recirculation pump 40 ,Lchnd 23 110
P4 Diluted CaCO 3 slurry pump 20 L 9 44
_________ ______________________________ second 94
El Flue gas cooler (heat exchanger) 3.54 x 1o4 -u, 14 72
E2 Clarified water cooler (heat exchanger) 2.39 x 105 hour 13 69
E3 Plate dryer 4700 L 1875 1875E3 _______________________________hour 587
F1 Filter press 25 h'u 852 852
K1 Flue gas blower 3000 u 5 15
Table 3.6: Equipment sizes and costs for base case Equipment costs were determined using
Aspen Process Economic Analyzer V7.2.1 where applicable. For equipment not available in
Aspen Process Economic Analyzer, estimated costs were provided from equipment vendors.
Costs are in US dollars for a US location in 2011.
Units Units $kCaCO3  Unit
Electricity Kwh 0.0138 0.068
Cooling water m3  0.0006 0.0005
Well cooling water m3  0.0058 0.0007
Air Nm 3  0.0037 0
Glucose kg 0.0025 0.112
Table 3.7: Operating costs for base case
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mineralization rates of 3X = 1.9 x 10- 3  oles and 10X = 6.3 x 10-3 were(L)(second) (L) (second)
evaluated in the process design. A 3X mineralization rate allows for the reduction of the
mineralization reactor size and a 1oX mineralization rate allows for the complete elimination
of the mineralization reactor. Interestingly, though, these improvements have little impact
on the cost of the CO 2 captured (reducing it from $399 per tonne to $386 per tonne for the
1oX rate). Next, the impact of culturing the yeast on the CO 2 capture cost was evaluated.
The equipment and associated costs for culturing the yeast were removed from the process
costs and it was assumed that the engineered yeast could be purchased from a third-party
vendor for a price of $2.5 -, which is a reasonable price for wild type S. cerevisae . This
change had about the same effect as the 1OX mineralization rate enhancement, reducing the
cost of CO 2 capture to $384 .
Since capital equipment expenses are the major driver of process cost, the most expensive
piece of equipment (the plate dryer, E3; Table 3.6) was removed from the process model.
The removal of this piece of equipment results in an end product that has 15% water, but
if there is no end-user specifying that the mineralized CO 2 must be dried, then this would
be a reasonable change to make to the process in order to reduce the CO 2 capture costs.
Removal of the plate dryer reduces the cost of CO 2 capture to $290 1 ne. Pursuing this
approach even further by removing the filter press, which is the second most expensive piece
of equipment, provides an additional savings of $50 ,,e (data not shown). It should be
noted, though, that this would result in significantly more circulation water lost with the
product (the filter press increases the solids percentage from 25% to 85%) and it would thus
require a larger product holding tank and more replacement water added at the beginning
of the process.
The impact that the engineered yeast has on the process costs was evaluated by adjusting
the process equipment sizes to handle the slower absorption and mineralization times. This
results in an estimated 15% increase in the capital equipment costs and an estimated 50%
increase in the electricity consumption for a final CO 2 capture cost of $433 .
Finally, two additional sources of CaO were evaluated: paper mill ash from a plant that
uses the Kraft process (with higher CaO concentrations than fly ash) and CaO that has
been leached from fly ash prior to the addition of the flue gas CO 2 . These two processes
would hypothetically result in higher concentrations of CaCO3 in the final product, and, of
the three sources of CaO, the paper mill ash is most intriguing because of the reduced cost
of CO 2 capture. It is important to note that this ash would have to be transported to the
CO 2 capture point, and transportation costs have been ignored in these calculations.
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Cost de- Percent
CaCO3 in Cost per Cost per crease cost de-
CaO product tonne of tonne (increase) crease
source (weight product of CO 2  per tonne (increase)
%) (tone) (ton*ne) of CO 2  compared
ton tonnes
tonne case
Base case (bCA2- Coal fly 26.7 47.0 399yeast) ash
3x mineralization Coal fly 26.7 46.8 398 1 0.3%
ratea ash
10x mineraliza- Coal fly 26.7 45.5 387 12 3.0%tion rate' ash
Externally pur- Coal fly
chased bCA2- 26.7 45.2 384 15 3.8%
yeast ash
No dryer in Coal fly 21.7 34.2 290 119 27.3%
process ash
No biological Coal fly
components (no as 26.7 51.1 433 (34) (8.5%)
CA2, no yeast)
No biological
components (no Coal flyCA2, no yeast), ash f 26.7 53.4 453 (54) (13.5%)
extra settling
tanks
Recombinantly Coal fly 26.7 53.4 454 (55) (13.8%)produced CA2 ash
Base case Paper mill 62.4 79.0 275 124 31.1%
Pre-
Base case carbonation 99.6 170 387 12 3.0%CaO leach-
ing
aHypothetical rate enhancement
b Removal of the plate dryer results in 15% water in the final product
Table 3.8: Process costs for different C02 mineralization process designs
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3.4 Conclusions
In this work, engineered S. cerevisae was used to enhance the hydration of CO 2 and the min-
eralization rate of CaCO3 . The enhanced rates were verified using quantitative techniques
in lab-scale measurements. In a variety of different tests, including pH and temperature
stability and CO 2 hydration activity, the bCA2-yeast performed as well as soluble bCA2,
which has a reported turnover rate of 1 x 106 1, Several possible mineralization pep-
tides were tested for CaCO 3 mineralization rate enhancement. At concentrations below 2 x
1012 peptides there was little to no effect on the mineralization rate for the yeast-displayed
peptides. At concentrations around 2 x 1012 Pptides, though, there was a roughly 50% increase
mLin mineralization rate, which appeared to be independent of the peptide sequence displayed.
Interestingly, even the yeast with no peptide displayed was able to increase the mineraliza-
tion rate by 20%-30% when tested at the same cell concentrations as the peptide-displaying
yeast.
The effect that these enhanced CO 2 hydration and CaCO 3 mineralization rates would
have on the CO 2 capture cost in a CO 2 mineralization process using coal fly ash as the CaO
source was then evaluated. The cost impact of the bCA2-yeast on the process is significant,
decreasing the predicted cost of CO 2 capture by 8.5% to 13.5%, when compared to a CO 2
mineralization process with no biological components. Interestingly, this process model also
predicts that the use of purified soluble, recombinant CA2 would not provide these same cost
savings (only accounting for the difference in production and purification costs and ignoring
the mineralization rate and settling rate effects).
If a downstream use can be identified for the product (the mineralized CO 2 and the
other solid contaminants introduced with the CaO), then the cost of CO 2 capture in this
process would be partially offset by the income received for the sale of the product. For
example, for the base case in Table 3.8, 1 tonne of captured CO 2 would generate 8.5 tonnes
of product (with 2.27 tonnes of CaCO3 in the product). Even if the product is only sold
for $10 1 , the cost of CO 2 capture would be reduced by as much as $851 of CO 2
captured. Moreover, the use of the product in downstream applications would obviate the
need to dispose of the coal fly ash in a landfill. Assuming a landfill disposal charge of $0.035
1, this would further reduce the cost of CO 2 capture by $262 1 if coal fly ash is usedkg' tonne C0 2
as the CaO source, by $72 o if paper mill ash is used as the CaO source, and by $6
tonne Co2 if pre-carbonation leached CaO is used. Thus, for the base case, the cost of CO 2
capture could be as low as $52 on c2 ($47 ton co2) if the landfill non-use credit is applied
and if the product is sold for $10 1 . While the total cost of CO 2 capture by this process
might be higher than the costs of other techniques for CO 2 capture, it is important to keep




3.5.1 Yeast display of enzymes
The cDNA's for bCA2 and hCA2 were cloned into the yeast surface display plasmid pCT-
CON2 using standard molecular biology techniques. All cloning steps were performed in E.
coli. Bovine CA2 cDNA in the pCMV-SPORT6 plasmid was ordered from Open Biosystems
(clone ID: 7985245; Accession number: BC103260). Human CA2 cDNA in the pDONR221
plasmid was ordered from the Dana Farber / Harvard Cancer Center DNA Resource Core
(plasmid ID: HsCD00005312; Refseq ID: NM_000067). The pCTCON2 plasmid was a gener-
ous gift from the Wittrup lab. Both CA2 genes contained internal BamHI restriction sites,
which were removed using a Stratagene Quikchange Lightning Site Directed Mutagenesis Kit
to make them compatible with the yeast display vector, pCTCON2. The genes were PCR
amplified off of the plasmids and an upstream NheI restriction site and a downstream BamHI
restriction site were added to make them compatible with the pCTCON2 plasmid. The yeast
display vector pCTCON2 and the bCA2 and hCA2 PCR products were digested with the
appropriate restriction enzymes and the digestion products were ligated into the vector. The
CAH gene (from S. thermophilus LMG 18311 (Accession number: YP_140076) was codon
optimized for S. cerevisae, then synthesized and cloned into the pCTCON2 plasmid by DNA
2.0. Deletion of the first 35 amino acids of the CAH protein was accomplished through site-
directed mutagenesis using the protocol described previously. [88] Correct insertion of the
genes of interest into the yeast-display plasmid was confirmed by DNA sequencing reactions
prior to transformation of the plasmids into competent EBY100 S. cerevisae cells. Trans-
formed cells were propagated in SD-CAA media. Expression of the hCA2, bCA2, and CAH
enzymes was induced by transferring the cells to fresh SG-CAA media at a concentration of
0.5 0D6 00 and growing them for at least 24 hours at 22'C.
mL
3.5.2 Yeast display of mineralization peptides
Mineralization peptides were codon optimized for S. cerevisae and were designed with the
appropriate restriction enzyme sites for cloning into the pCTCON2 plasmid using the Gene
Designer program from DNA 2.0. Oligonucleotides were synthesized using solid phase syn-
thesis by IDT. The oligonucleotides were annealed, phosphorylated and inserted into the
pCTON2 plasmid. Correct insertion of the genes of interest into the yeast-display plasmid
was confirmed by DNA sequencing reactions prior to transformation of the plasmids into
competent EBY100 S. cerevisae cells. Transformed cells were propagated in SD-CAA me-
dia. Expression of the hCA2, bCA2, and CAH enzymes was induced by transferring the
cells to fresh SG-CAA media at a concentration of 0.5 O00 and growing them for at least
24 hours at 22'C.
3.5.3 Measuring yeast display expression levels
Expression levels were measured as described previously. [89] After expression, 0.2 OD6 00
cells were washed three times with 700 pL cold IX PBS, 5 m bovine serum albumim,
sterile filtered (PBS-BSA). Washing consisted of spinning the cells, removing supernatent,
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and resuspending in wash solution. The cells were then resuspended in 100 PL of a 1 to 200
dilution of AlexaFluor 488 conjugated antibody (mouse anti-cmyc 9B11 or mouse anti-HA
16B12) diluted in PBS-BSA. The cells were incubated for 30 to 60 minutes on ice. The cells
were washed twice with PBS-BSA and were resuspended in 750 pL PBS-BSA. Cells were
analyzed on a BD FACScan flow cytometer.
3.5.4 Calculating yeast display expression levels
A Quantum Simply Cellular anti-Mouse IgG kit was used to quantitate the levels of expressed
c-myc or HA epitopes on the yeast cells according to the directions in the kit. Briefly, four
populations of beads, each with a different level of antigen binding on it were stained with
the same AlexaFluor 488 conjugated mouse antibody that was used to label the yeast cells.
A fifth, unstained population of beads was added after staining and the beads were analyzed
on a BD FACScan flow cytometer using the same settings and on the same day as the yeast
cells. A calibration curve was established by plotting the antibody binding capacity versus
the peak channel for each population of stained beads. The Bang's Lab calibration file was
used to provide a calibration curve.
The auxotrophic marker that is used to maintain selective pressure on the cells to retain
the pCTCON2 yeast-display plasmid is not 100% effective. Thus, in any population of
EBY100 cells that have been transformed with the pCTCON2 plasmid, some fraction of
the cells do not express and display the protein of interest. Moreover, within the positive
population of cells, there is a range of expression levels. This, in turn, affects the total
numbers of proteins for the entire population of cells. To account for this for this, the
flow cytometry data was processed by first calculating the percentage of cells that was
expressing the full-length protein or peptide. The geometric mean of the positive population
of cells was used to determine the average expression level per cell using the calibration
curve from the Bang's lab beads. The "number of proteins per population of cells" was
then calculated by multiplying the "percent expressing" by the "average expression level."
If a positive population had a high and a low expression population, they were treated as
separate populations and the sum of these was the number of proteins per population of
cells.
3.5.5 Carbonic anhydrase activity assay
To test the activity of carbonic anhydrase isoforms, a modified version of the Wilbur-
Anderson method was used. [72] First the cells expressing the carbonic anhydrase were
washed three times in distilled water. The cells were then resuspended in fifteen mL of the
chilled assay buffer. Carbon dioxide gas was bubbled through a flask of stirred distilled water
that was packed in ice for at least one hour to reach CO 2 saturation in the liquid (roughly
67 mM CO 2 at 3'C). The reaction buffer, Tris-HCl, pH 8.8 (0.02 M) was chilled on ice for
at least 1 hour. A pH electrode was 3-point calibrated at 3C. For the blank, fifteen mL
of the Tris-HCl was added to a clean glass beaker with a small stir bar sitting in an ice
bath. For the soluble carbonic anhydrase experiments, the enzyme was added to the buffer.
For the carbonic anhydrase displaying yeast cells, fifteen mL of the cells in assay buffer was
added to the clean glass beaker with a small stir bar sitting in an ice bath. The pH electrode
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was added and allowed to reach equilibrium. Using the RS232 port, the data was collected
and saved onto an attached computer. Once equilibrium was reached, 10 mL of the CO 2
saturated water was added. The pH was recorded every 1.5 seconds by the pH meter and
saved to the computer. The raw pH values were converted to delta pH values (max pH - pH
at time t). The delta pH values were converted to percent reaction complete values (e.g.,
0% for t 0 to 100% when the pH reached equilibrium).
3.5.6 Calculating activity of carbonic anhydrase
Using the data collected from the carbonic anhydrase activity assay, carbonic anhydrase
activity was calculated using a modified version of Wilbur-Anderson units. [72] The units of
activity per nM of enzyme were calculated normalizing to the blank reactions
(Tblank average - Tample average)/(Tsample average) (3.8)
where Tblank average is the average of the times that it took the blank reactions to reach 50%
completion and the Tsample average is the average time it took the sample reaction to reach
50% completion. Fifty percent completion was chosen because this was the point at which
some of the reactions reached an inflection point (see Figure 3.3). This inflection point was
probably due to the weaker buffering capacity of tris buffer below pH 7.5.
3.5.7 Carbonic anhydrase stability studies
For the temperature stability studies, carbonic anhydrase displaying yeast or soluble carbonic
anhydrase was resuspended in assay buffer either at the concentration to be used in the final
assay (in the case of yeast displayed enzyme) or to a concentration of 0.1 m (for the soluble
carbonic anhydrase). The samples were then stored at 4C or in a 50'C oven in sealed
containers (to avoid evaporation of the buffer). For the pH stability studies, the samples
were resuspended in buffers of the appropriate pH and were stored at 4C in sealed containers.
Prior to use in the assay, the samples were then washed and resuspended in cold assay buffer.
The buffers used for the pH studies were: 65 mM Phosphate-Citrate buffer, pH 3.0; 72 mM
phosphate-citrate buffer, pH 5.0; distilled water, pH 6.0; 81 mM phosphate-citrate buffer,
pH 7.0.
3.5.8 Mineralization rate measurement
The mineralization rate of calcium carbonate was measured using calcium sensitive elec-
trodes. The probes were calibrated using three standard solutions of 0.01 M, 0.05 M, and
0.1 M calcium chloride. Then 7.5 mL of 0.2 M CaCl2 was placed in a 50 mL falcon tube with
a magnetic stir bar and the tube was placed on a magnetic stir plate. 0.3 mL of calcium ionic
strength adjuster (Orion 932011) was added to the solution and the stirring was set to 850
RPM. The yeast cells were prepped by washing several times with distilled water and then
either 180 OD6 00 or 18 OD 600 of cells were resuspended to a final volume of 7.7 mL (for the 2
x 108 or the 2 x 10 7 ell, samples, respectively). The calcium ion electrode was added to the
sample and allowed to equilibrate. Then 2.5 mL of 0.1 M NaHCO 3 was added using a syringe
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pump set to inject at 5 'L and the change in calcium ion concentration was measured. Usingmin
the RS232 port, the data was collected and saved onto an attached computer. The slope of
the change in calcium ion concentration was calculated and converted to a value with units
of "" . Each peptide and concentration was measured in duplicate and values reported
in Vigure 3.7 are averages of these measurements. The sample was then saved and analyzed
by light microscopy and by x-ray diffraction, to confirm presence of calcium carbonate.
3.5.9 Cross-polarized microscopy and X-ray diffraction analysis of
crystals
Samples for microscopy were prepared by pipetting a small aliquot directly out of the min-
eralization reaction onto a glass slide and covering with a glass coverslip. Cross-polarized
microscopy was performed using orthogonal polarizing filters before and after the sample.
XRD samples were prepared by taking ~ 50 mL out of a reaction, centrifuging for 10 min-
utes it to pellet the sample, and removing the supernatent by decanting. If necessary, the
sample was resuspended in a small amount of distilled water. The sample was pipetted into
an x-ray diffraction (XRD) sample holder. The sample was placed at 80'C to dry and was
analyzed on a Rigaku Powder Diffractometer using a 10 minute scan. Crystal structure was
verifed by comparing to appropriate standard reference cards.
3.5.10 Process modeling
Microsoft Excel was used to calculate the mass balances at each process stage for the various
species involved in the CO 2 capture process, including nitrogen, oxygen, carbon dioxide,
the components of fly ash (or paper mill ash) water, calcium oxide, yeast, glucose, and
the mineralized carbonate product. These mass balances were used to determine the min-
imum process equipment sizes. Those dimensions were used to determine the appropriate
equipment dimensions, the associated capital costs, and the associated direct, indirect, and
operating costs for the process in Aspen Process Economic Analyzer V7.2.1. These costs
were then aggregated and converted to a cost per tonne of CO 2 captured or per tonne of
product produced based on the CO 2 flux and the process production rates.
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Chapter 4
Optimization of M13 bacteriophage
pVIII library construction process for
histidine-biased libraries
4.1 Summary
Biased peptide libraries are useful for focusing library screening efforts on peptides with pre-
defined characteristics. In this work, the aim was to develop histidine-biased libraries on the
major coat protein (pVIII) of M13 bacteriophage (M13 phage, or phage), as histidines are
critical in many biological processes. Histidines can effectively coordinate first row transition
metals like zinc, copper, and nickel. Histidines have a pKa that is very close to physiological
pH and they play a critical role in the active sites of many enzymes. [90] The imidazole ring
on histidines can also form ir-stacking interactions. [91] To this end, a vastly improved M13
phage pVIII library construction protocol was developed, which led to the construction of
high-quality, histidine-biased libraries. The improvements included optimization of several
cloning steps and, after a quantitative analysis of the impact that amplification time had on
library quality, the selection of a 3-hour amplification time. This protocol was then used to
create libraries with histidines in positions 3 and 5 or 4 and 6 in the N-terminal peptide insert
of pVIII as well as a histidine mutation at the twenty-third residue in the pVIII backbone.
4.2 Introduction
The pVIII protein is 55 amino acids long and forms an alpha helix (see Figure 4.1a). There
are 2700 copies of the pVIII protein arranged in a helical array around the M13 genome.
Figure 4.1b shows a reconstruction of the likely arrangement of 60 of the pVIII proteins
based on TEM images of full M13 phage, with the pVIII from Figure 4.1a still highlighted
in red. [92] Each pVIII protein comes into contact with three other pVIII proteins, and the
overall arrangement is very regular. The first 28 amino acids of pVIII (those that are most
solvent accessible) are listed in Figure 4.1c. To make a pVIII library, residues 2-4 (EGD)
are replaced with a library of 8 amino acid peptides. Those 8 amino acids are referred to
hereinafter as 1 through 8. After those 8 amino acids, the wild-type pVIII sequence resumes
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with an aspartic acid (D5 ) and the subsequent residues in the pVIII protein are referenced
using their position in the wild-type sequence (e.g., Q15). A single phage sequence with
three histidines in it (two in the peptide insert and one in the backbone) would be called
xxHxHxxx-23H, where the x's represent any amino acid and the 23H denotes the presence of
a G23H mutation in the backbone. A pVIII library with the third and fifth positions locked




N-terminus - A EGD D5 PAKAA10 FNSLQ15 ASATE20 YIGYA25 WAM... - c-terminus
X1X2X3 X4 X5X 6 X7X 8
Figure 4.1: M13 phage p VIII protein structure and sequence (a) The crystal structure of a
single pVIII protein (from PDB file 1IFJ) with the N-terminus on the left and the C-terminus
on the right. The pVIII protein forms an alpha helix. [92] (b) A reconstruction of 60 pVIII
proteins of M13 viral capsid based on TEM images of M13 phage. [92] The pVIII protein
from (a) is highlighted in red. (c) The first 28 amino acids of wild-type pVIII protein. The
three residues that are replaced with the 8 amino acid peptide library are highlighted in red.
The numbering convention in this scheme assigns 1 through 8 to the peptide library and 5
to 28 to the rest of the pVIII residues.
4.3 Results
4.3.1 Improvement on pVIII library construction process
Previous work in the Belcher lab led to a greatly improved pVIII library construction pro-
cess. [93] Improvements included the use of longer oligonucleotides for easier agarose gel
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purification and some improved DNA purification steps, which led to pVIII libraries that
were sufficient for identification of a carbon-nanotube-binding pVIII sequence. [94] Despite
these improvements, there were several characteristics of this improved process that limited
its use for the construction of histidine-biased libraries. Wild-type M13 phage prefers to
have negatively charged amino acids on the N-terminus of the pVIII protein and positively
charged residues on the C-terminus to interact with the negatively charged DNA enclosed
in the viral capsid. The replacement of negatively charged residues on the N-terminus with
positively charged residues affects viral capsid assembly and growth rate. M13 pVIII libraries
with large numbers of histidines are slow growers and are thus prone to contamination by
fast growing M13 sequences.
The cloning techniques used in library construction also make it very difficult to eliminate
completely the presence of the parental M13 sequence. If the parental sequence has a faster
growth rate than the library sequences (for example, if the parental has more negative
residues on the N-terminus than the library), then the parental sequence will overgrow the
library sequences and reduce the library diversity. Finally, M13 phage resists modifications
made to the pVIII sequence such that it will make mutations or truncations to the 8-mer
peptides added on the N-terminus in order to return to a sequence that is closer to wild-
type. The more time that a population of engineered-pVIII M13 phage spends in a growth
environment (i.e., during E. coli amplification), the more likely those phage are to return to
a wild-type-like pVIII sequence.
With those limitations in mind, additional improvement to the pVIII library construction
protocol were introduced to increase the library size and quality. These improvements are
listed and discussed below. A general overview of the library construction process is shown
in Figure 4.2. The full protocol is written out in Section 4.5.5. Table 4.1 summarizes the
average yields of each step in the process for four libraries made using the final protocol.
" Full randomization of position 1 provides greater sequence diversity The
previous library construction protocol resulted in amino acid 1 of the peptide insert
being limited to five residues. This was an artifact of the restriction enzymes that
were used in earlier protocols. However, digestion with BamHI and BspHI results in
restriction sites that are far removed from the library insert position, meaning that the
first position can be fully randomized, instead of being restricted to only five amino
acids. This increased the theoretical diversity of the library by a factor of four (from
5 possible residues to 20 in position 1).
" Selection of a parental sequence with a growth rate that matches that of the
library sequences improves library diversity The results in this work identified
the relative growth rates of sequences as a critical parameter. pVIII sequences that
led to faster assembly into a full phage ended up dominating a library within just a
few hours of amplification. This phenomenon has been identified by others and was
described in a mathematical model by Derda, et al. [95] In that model, a 10 minute
difference in secretion time between two phage led to a 5 to 1 difference in abundance
after just 5 hours of amplification.
Since it is very difficult to completely eliminate parental sequence from a library, it is
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Figure 4.2: Outline for M13 p VIII library construction (a) The first step in making a pVIII
peptide library is to purify a large quantity of parental M13 DNA from an infected batch of E.
coli. One hundred pg of DNA is a reasonable amount in order to ensure a sufficient quantity
for downstream use. The numbers on the right of the diagram show roughly the quantity of
DNA remaining after each step. Table 4.1 shows the actual amounts remaining after each
step for the final protocol (average results from four libraries). (b) After isolating the DNA,
the parental DNA is digested to remove the pVIII protein region where the peptide will be
inserted. The oligonucleotide library that encodes the peptide inserts is digested in parallel
with the parental DNA. (c) The parental DNA is purified and dephosphorylated to minimize
self-ligation, and (d) the digested oligonucleotide library is ligated into 2 pg parental vector.
(e) The ligation reaction is cleaned, concentrated, and transformed into competent E. coli
cells. After a 45-minute recovery period, a small quantity of infected cells is titered to assess
phage concentration (Figure 4.4) and the diversity of peptide sequences (Figure 4.3). At this
stage, only one copy of each sequence is present. (f) The final step is to amplify these phage
so that at least 10 3 copies of each sequence are present. The bulk of the cells are grown
for 3 hours in 400 mL of LB. (g) The amplified phage library is then purified, concentrated
and assessed for the total phage amount (Figure 4.5a) and diversity (Figure 4.5b). The full
protocol is available in Section 4.5.5.
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Mass left from
Step Average yield Average yield 100 pg start-for this step from start ing parental
vector
After digestions 56% 56% 56 pg
After gel extrac- 30% 15% 15 pg
tion
After dephos- 68% 10% 10 pg
phorylation
Into ligation 27 % 2% 2 pg
(only use 2 pg)
After ligation,
purification, and 52% 1.3% 1.3 pg
concentration
Table 4.1: Typical yields for each step in the p VIII library construction process These aver-
ages are from the libraries that were made using the final protocol that is listed in full in
Section 4.5.5 (Libraries 6-9). Note that the average yield after dephosphorylation (10 pg)
is several-fold higher than the amount of DNA used in the ligation reaction (2 pg). This
means that a larger ligation reaction can be performed, which would yield more DNA for
the subsequent transformation reactions. Alternatively, the digested and dephosphorylated
parental DNA can be used for more than one ligation reaction (i.e., for the construction of
multiple libraries in parallel).
85
than the sequences in the library. Thus, the libraries constructed for this work were
built using a triple-His sequence (ESHTHGNE-23H), which is based on M13SK, as the
parental sequence. [96]
" Starting library construction process with a larger amount of DNA (>100
jig) increases library size As shown in Figure 4.4, the amount of DNA used for trans-
formation affects the size of the library. By starting with 100 pg of parental DNA,
the protocol developed in this work delivered at least 10 pg of digested, dephospho-
rylated DNA ready for ligation, which was 5 times more than needed for the ligation
reaction (2 pg). A 2 ig ligation reaction typically yielded around 1.3 pg of DNA for
the transformation reactions (see Table 4.1). The results from this work clearly show
that the amount of DNA used in the transformation reaction has an impact on the
total library size, with libraries of 1 x 107 sequences (measured by counting the plaque
forming units or PFUs) coming from transformations with ~ 1 pg (see Figure 4.4).
These libraries were close to the theoretical maximum for the triple-His libraries (205
x 13 = 3.8 x 107), which have two His locked in the 8 amino acid peptide insert (see
Figure 5.2) and the last residue limited to codons ending with the nucleotide G. Future
protocol optimization will include investigation of the impact of doubling the ligation
size (to 4 pg), which would yield even more DNA for the subsequent transformations.
" Optimization of cloning steps, including using a double digest with BamHI-
HF and BspHI instead of sequential digestions with BamHI and BspHI,
enhances DNA yields The largest improvement in yield was achieved by combining
the BspHI and BamHI digestions in one double digestion reaction instead of performing
them sequentially. This was made possible with the introduction of the enzyme BamHI-
HF, which has high activity in the same buffer as BspHI (NEB Buffer 4) and the
same restriction site specificity of BamHI. This also had the advantage of reducing
the digestion time from a total of 7 hours (3 hours for the first digestion, an hour for
cleaning and preparing the next digestion, and 3 hours for the second digestion) to
3 hours (3 hours for the double digestion). This reduction in digestion time made it
possible to condense all of the DNA manipulation steps (annealing, extending, parental
purification from E. coli, digestion, dephosphorylation, and ligation) into one day of
work (see Section 4.5.5).
* Using fresh (not frozen) DNA increases DNA yields and library size The
quality of the libraries was improved by emphasizing not freezing any DNA during the
library construction process. Based on anecdotal evidence that freezing DNA at any
point in the cloning process could reduce the efficiency of subsequent steps (digestions,
ligations, transformations), the entire library construction process was coordinated so
that naked DNA was never frozen. In other words, the times of each step and the
overall process flow were set so that the only overnight stop point during the DNA
manipulation steps occurred during an overnight ligation.
The impact that frozen ligated DNA potentially can have on library size can be seen
by looking at the results for Library 9, which has much lower diversity than Libraries
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Figure 4.3: Pre-amplification library quality This data represents the results of the library
quality after step (e) in Figure 4.2. The libraries are listed in chronological order. The
percent unique sequences was calculated by dividing the number of unique sequences by
the total number of sequences analyzed (15 to 45 sequences analyzed per library). The
majority of the non-unique sequences were parental sequences, with the occasional mutation
or truncation. The libraries marked with a (*) were all made with the process listed in
Section 4.5.5, with the exception that the ligation reaction was stored frozen for 1 week prior
to transformation for Library 9. Library process improvements do not seem to have affected
the percent unique sequences.
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Total DNA used for transformation (ng)
Figure 4.4: Pre-amplification library size This data represents the results of the library
size after step (e) in Figure 4.2. Total library size was calculated by plating 10 pL of the
transformation reaction, calculating PFU and multiplying by total transformation volume.
The red dotted line indicates the theoretical maximum diversity for a biased pVIII peptide
library with 5 fully randomized and 1 partially randomized position (20' x 13). The libraries
marked with a (*) were all made with the process listed in Section 4.5.5, with the exception
that the ligation reaction was stored frozen for 1 week prior to transformation for Library 9.
There is a clear relationship between total amount of DNA used in transformation and the
total size of the library.
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6-8, with the exception that the ligated DNA was stored frozen for 1 week prior to
being transformed into E. coli for amplification.
Reducing amplification time to 3 hours achieves optimal balance of library
quality and fold amplification As discussed above, the relative growth rates of
different phage sequences in a population of M13 phage can lead to a faster growing
sequence taking over a population. The final step in making an M13 pVIII library is
to amplify the library. Prior to amplification, only one copy of each phage sequence
is present. Screening of libraries typically calls for a 600-fold oversampling in order
to account for a 95% chance of sampling each sequence and for the differences in
abundances caused by differences in the genetic code. [97] Moreover, given that the
time and material resources that are required to create a library are significant, it is
desirable to make enough of the library so that it can be screened more than one time.
It is reasonable to target 10 screens per library batch made. Using these values in the
equation below:
Fold amplification - (fold oversampling)(screens per batch)
6x10 3
gives a value for the desired fold amplification. Fold amplification is only one compo-
nent of the final library quality, and any analysis of a library protocol must incorporate
the other component - the percent unique sequences.
With these two metrics in mind, nine M13 triple-His pVIII libraries were amplified (step
(f) in Figure 4.2). The fold amplification and the percent unique triple-His sequences
were calculated at several amplification time points. The results are summarized in
Figure 4.5. The original pVIII library protocol called for an amplification time of 5-7
hours. It was obvious for the triple-His pVIII libraries, however, that even a five-
hour amplification would be too long, because at five hours the percent unique triple-
His sequences was reduced to less than 30%. Even more problematic was that more
than 50% of the sequences were truncations and mutations (sequences without three
histidines). These sequences grow much more quickly than triple-His sequences and
completely take over a phage population in just a few more hours of amplification (data
not shown). However, this work demonstrated that a 3-hour amplification provides
sufficient fold amplification (average fold amplification 3 hour, = 104) while minimizing
the truncations and mutations (< 10%). The increase in the parental sequence at 3
hours is concerning in that it reduces the total diversity of the libraries, but since the
parental sequence is a triple-His, it is less concerning than the presence of mutation
and truncation sequences.
4.3.2 Histidine-biased libraries with three histidines in every
copy of pVIII
As discussed above, there are limitations on the diversity of a pVIII library that are





























Figure 4.5: Library amplification time and its influence on fold-amplification and library
quality (a) Fold-amplification was calculated by dividing the library size at each time point
by the pre-amplification library size (time = 0). (b) At each time point, phage plaques were
sequenced and the quality of the library was assessed by calculating percent unique triple-
His sequences, parental sequence, and truncation and mutation sequences. All nine libraries
were assessed at 0 hours. Three libraries were assessed at 5 hours, one was assessed at 4.5














the N-terminus of pVIII is difficult, though this work has shown that it is not impossi-
ble. Not surprisingly, nearly every pVIII peptide insert that was sequenced had a net
neutral or negative charge. In other words, for every positively charged histidine in-
serted into the pVIII, there was a charge-balancing aspartate or glutamate. There were
also very few positively charged lysine or arginine residues expressed in the histidine-
biased libraries. The libraries were also essentially devoid of bulky aromatic residues
and cysteines. Figure 4.6a shows the prevalence of each amino acid at each position
in the peptide insert (1-8) for 212 clones that were sequenced from several builds of
a His3,5,23 library (i.e., this data is a compilation of all His3,5,23 sequences, not just
those from a single library).
In addition to limitations on the expression of certain residues in the N-terminal pVIII
insert, there also seem to be preferred locations for certain residues. Figure 4.6b is a
contour plot view of the same data from Figure 4.6a and Figure 4.6c shows the same
analysis for all of the His4,6,23 phage that were sequenced. It appears that aspartates
and glutamates are preferentially expressed on the N-terminal end of the insert. This
is not altogether surprising, given that an aspartate and glutamate are present in
positions 2 and 4 in the wild-type sequence, though one might have expected them to










































Figure 4.6: Positional amino acid diversity of triple-His libraries These triple-His libraries
have two His residues locked in either positions 3 and 5 (a) and (b) or 4 and 6 (c) and the
third His is located in the pVIII backbone at position 23. The percentages shown in these
charts represent the percent of sequences expressing that amino acid at that position. 212
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4.4 Conclusion
The protocol that was developed in this work was optimized for the construction of histidine-
biased libraries. Some of the parameters might not be optimal for non-biased pVIII libraries
(such as shorter amplification time), while others are likely to be beneficial for any pVIII
library (using a parental sequence that matches in growth rate with the rest of the library).
Any new type of pVIII library will need to be evaluated for the diversity and the fold
amplification, much as the histidine-biased libraries in this work were evaluated, and all of
the factors discussed in this work will need to be considered for future library protocols. It is
anticipated that the lessons learned as part of the histidine-biased library optimization will
prove useful and informative for future library construction.
Finally, it is worthwhile to discuss the implications of the differential growth rates on
downstream use of pVIII libraries. For most applications, the completion of a high diversity
library with > 104 copies of each sequence is only the beginning. The next step for most
projects is to perform a biopanning experiment and to identify M13 phage that are displaying
pVIII proteins of novel functionality. However, even if the percentage mutant and truncation
sequences is low prior to biopanning, they are often still present (or, possibly, they are likely
to form during amplification by utilizing E. coli's DNA recombination pathways). After
the selection round in biopanning, which might reduce the total number of phage from 108
to fewer than 104 , for example, one must amplify the phage to achieve a sufficient number
of each sequence for the next round of selection (see discussion about fold amplification
above). For the histidine-biased libraries, this amplification always resulted in a complete
overgrowth of mutant and truncated sequences (data not shown) after only one round of
selection. Biopanning often requires three to five rounds of selection (with amplification
in each round), and this was not possible using normal amplification protocols (even if the
amplification time was reduced to three hours). As such, alternative amplification protocols
will need to be investigated. Fortunately, one such protocol already exists: the use of
microgels for isolation and amplification of individual phage sequences in a massively parallel
fashion. [98] Future work with the histidine-biased libraries for biopanning applications will
benefit from the use of microgel amplification.
4.5 Experimental
4.5.1 Library primers
The oligonucleotide for the library extension primer has the sequence: 5-TTAAT GGAAA
CTTCC TCATG AAAAA GTCTT TAGTC CTCAA AGCCT CTGTA GCCGT TGCTA
CCCTC GTTCC GATGC TGTCT TTCGC TGCA -3. The oligonucleotides for the biased
libraries are variations on the following sequence: 5'-AAG GCC GCT TTT GCG GGA TC
CNN MNN MNN MNN GTG MNN GTG MNN TGC AGC GAA AGA CAG CAT CGG
AAC GAG GGT AGC AAC GGC TAC AGA GGC TTT-3'. In this sequence, codons 2 and
4 were locked as histidines, but similar primers were made with codons 3 and 5 or 4 and 6
locked.
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4.5.2 Measuring phage concentration with a UV-Vis spectropho-
tometer
The absorbance of a phage solution was measured on a Nanodrop UV-Vis spectrophotometer
(path length =1 mm). The following equation was used to calculate the concentration:
(A269 - A320 )(6 x 1017) PFU
7222 bp mL
for each phage sample.
4.5.3 Media and solutions for phage handling
The recipes for making agarose top, LB medium, IPTG/Xgal/Tet plates, SOC medium,
Tetracycline stock, TBS, and PEG/NaCl are available in the NEB Ph.D. Phage Display
Libraries Instruction Manual (New England Biolabs).
4.5.4 Measuring phage concentration by titering
To 150 pL of an overnight culture of XL-1 Blue E. coli cells, 10 pL of phage sample (or
diluted phage sample) was added. Four to five mL of melted agarose top (cooled to <
50'C) was added, swirled vigorously to mix, and the mixture was poured onto a warmed
IPTG/Xgal/Tet LB agar plate. Agarose top was allowed to cool, then the plate was placed
at 37'C for overnight. After overnight incubation, the number of plaques was counted (each
representing a single phage infection event) to determine the number of PFUs (plaque forming
units). To calculate concentration, the dilution factor was multiplied by the concentration
number of PFUs per pL of phage solution plated.
4.5.5 Library construction protocol
Make 400 mL autoclaved LB in a 2 L flask for day 2.
1. Preparation of pVIII library inserts
Perform these steps in parallel with miniprepping of the vector DNA.
(a) Annealing
* 44 pL TE with 100 mM NaCl (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 100
mM NaCl)
* 3 pL 100 pM pVIII library extension primer
* 3 pL 100 pM library oligonucleotides (300 pmoles, 5 pag oligo)
* 50 pL Total volume
Place in the thermocycler with the following conditions. It should take about 30
minutes.
* 95'C for 8 minutes
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" Ramp down to 25'C at a rate of 0.1 degrees
second
" Hold at 25'C
(b) Extension
* 50 pL annealed reaction
* 20 pL (lOX) Klenow buffer (NEB Buffer 2)
* 8 pL Klenow fragment (5 US) = 40 units
* 8 pL of 10 mM dNTP's
* 114 pL ddH2 0
* 200 pL Total volume
Aliquot 50 pL into each of 4 PCR tubes and place in thermocycler with the
following conditions.
" 37'C for 20 minutes
" 65'C for 20 minutes
(c) Recombine aliquots and purify DNA.
Add 3 volumes buffer QG (600 pL) and 1 volume isopropyl alcohol (200 PL) to
the recombined DNA. Using the DNA Gel Extraction Kit from Qiagen (page 25 in
the QlAquick Spin manual), purify the annealed and extended oligonucleotides.
Elute the purified DNA in 50 pL of prewarmed EB (microwave for ~ 10 seconds
to warm EB to around 50'C). Let the EB sit on the column for three minutes
before eluting. These two steps increase the yield of DNA.
Measure the concentration and calculate the total mass of DNA:
48 pL x "_ _= ng (4.2)
pL
(d) Double digest of pVIII library oligonucleotides using BamHI-HF and BspHI
Perform this digest in parallel with the vector digestion.
i. Total reaction volume = 200 pL; 20 pL per 0.5 pg of DNA; only add 5 pg of
oligo DNA
ii. Save 4 pL for the negative control (uncut) sample
e pL extended reaction (5 pg DNA)
o 20 pL (lOX) NEB buffer 4
o 2.5 pL BamHI-HF
o 5 pL BspHI
e pL ddH20
e 200 pL Total volume
iii. Digest in 1.5 mL tube at 37'C for at least 3 hours. No heat kill necessary.
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iv. Using the DNA Gel Extraction Kit from Qiagen (page 25 in the QlAquick
Spin manual), purify the digested oligonucleotides. Elute the purified DNA in
50 pL of prewarmed EB (microwave for a 10 seconds to warm EB to around
50'C). Let the EB sit on the column for three minutes before eluting. These
two steps increase the yield of DNA.
Measure the concentration and calculate the total mass of DNA:
ng
48 pL x ng (4.3)
(e) Agarose gel purification of digested pVIII library oligonucleotides
Perform this in parallel with the gel purification of the digested vector.
i. Make 3% agarose gel by adding 3 grams of agarose to 100 mL of TBE. Add
1.0 pL SYBR Safe (10,OOOX) after the gel is partially cooled and pour into
gel holder (a 70 mL for 1 gel). Use the 8 well comb to create wells.
ii. Prepare DNA samples
" Double digested DNA = 44 pL of digested DNA and 9 pL NEB orange
loading dye
" Uncut DNA = 4 pL uncut DNA, 6 pL ddH20, and 2 pL orange loading
dye
" DNA ladder =1 pL 100 bp NEB ladder, 11 [pL ddH20, and 2 pL orange
loading dye
iii. Load a 55 pL per well.
iv. Set voltage to 90V and run for a 60 minutes, checking the gel frequently.
v. While gel is running, preweigh 2.0 mL eppendorf tubes for gel extraction.
vi. Use blue light imager to verify that DNA is cut before extracting the digested
DNA bands.
vii. Using the DNA Gel Extraction Kit from Qiagen (page 25 in the QlAquick
Spin manual), purify the DNA. Do not put more than 2400 pL of dissolved
sample on one column. Use Table 4.3 to calculate volumes of QG and iso-
propanol. Elute the purified DNA in 50 pL of prewarmed EB (microwave for
_ 10 seconds to warm EB to around 50'C). Let the EB sit on the column
for three minutes before eluting. These two steps increase the yield of DNA.
2. Preparation of M13SK vector
Perform these steps in parallel with preparation of library oligo DNA.
(a) Extraction of M13SK vector DNA from E. coli cell pellets
Always prepare the M13SK vector DNA on the same day as the digestions. Fresh
parental DNA from frozen cell pellets provides better yields in subsequent steps.
The frozen cell pellets should have been saved in a 200 pL volumes in 1.5 mL
tubes from a previous phage amplification (8 hour to 16 hour growth) and the
sequence should be previously verified by DNA sequencing (from one tube). One
liter of amplified phage should provide between 8 and 16 of these pellets.
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i. Prep three tubes of parental DNA. This should provide more than 100 pg of
DNA, using QlAprep Miniprep kit (page 22).
ii. Elute the purified DNA in 50 pL of prewarmed EB (microwave for ~ 10
seconds to warm EB to around 50'C). Let the EB sit on the column for three
minutes before eluting. These two steps increase the yield of DNA.
iii. Mix all the DNA samples together, measure concentration, and calculate total
mass.
rig_pL x " L ng (4.4)
(b) Double digest of parental vector DNA using BamHI-HF and BspHI
Perform this digest in parallel with the library oligonucleotide digestion.
i. Total reaction volume = 2000 pLL; 200 pL per 5 pg of DNA; total of 50 pg of
vector DNA
ii. Save 4 pL
iii. Use Table
for the negative control (uncut) sample.
4.2 to set up digestion reactions.
Volume for Number of Volume for Volume for
Sample 1 reaction parallel re- master mix one-half
(pL) actions (pL) (sem)(pL)
Vector DNA 10
NEB Buffer 4 (lOX) 10
BamHI-HF 2.5 10 25 12.5
BspHI 5 10 50 25
ddH20 10
Total 200 10 2000 1000
Table 4.2: Table for calculating p VIII library vector digestion volumes
iv. Digest in 1.5 mL tube at 37'C for at least 3 hours (preferable 4 hours). No
heat kill necessary.
v. Using the DNA PCR Purification Kit from Qiagen (page 19 in the QlAquick
Spin manual), purify the digested oligonucleotides. Purify using 5 columns
(10 pg DNA per column). Elute the purified DNA from each column in 50
pL of prewarmed EB (microwave for ~ 10 seconds to warm EB to around
50'C). Let the EB sit on the column for three minutes before eluting. These
two steps increase the yield of DNA.
Measure the concentration and calculate the total mass of DNA:




(c) Agarose gel purification of digested parental vector
Perform this in parallel with the gel purification of the digested library oligonu-
cleotides.
i. Make two 0.8% agarose gels by adding 1.2 grams of agarose to 150 mL of
TAE. Add 1.5 pL SYBR Safe after the gel is partially cooled and pour into
gel holder (= 70 mL for 1 gel). Use the 8 well comb to create wells.
ii. Prepare DNA samples
" Double digested DNA = 240 pL of digested DNA and 48 pL NEB blue
loading dye
" Uncut DNA = 4 pL uncut DNA, 6 pL ddH20, and 2 pL blue loading dye
" DNA ladder 1 pL 1 kbp NEB ladder, 11 pL ddH20, and 2 pL blue
loading dye
iii. Load _ 55 pL per well. (Will probably need 6 wells for parental vector
digestion reaction.)
iv. Set voltage to 90V and run for ~ 60 minutes, checking the gel frequently.
v. While gel is running, preweigh 2.0 mL eppendorf tubes for gel extraction.
vi. Use blue light imager to verify that DNA is cut before extracting the digested
DNA bands.
vii. Using the DNA Gel Extraction Kit from Qiagen (page 19 in the manual),
purify the DNA. Use Table 4.3 to calculate volumes of QG and isopropanol.
Do not put more than 2400 pL of dissolved sample on one column. Elute
the purified DNA in 50 puL of prewarmed EB (microwave for ~ 10 seconds to
warm EB to around 50'C). Let the EB sit on the column for three minutes
before eluting. These two steps increase the yield of DNA.
Gel weight Volume QG Volume iso-










Table 4.3: Table for calculating p VIII library gel extraction volumes
3. Calculation of DNA concentrations after digestion and purification
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Mix all the parental DNA together and then measure the concentration and calculate
the total mass of DNA for the parental vector and the insert:
nig_
Digested parental vector: pL x = _ ng (4.6)
p L
ng
Digested oligonucleotide insert: pL x ng (4.7)
puL
4. Dephosphorylation of vector to prevent self-ligation
(a) Prepare reaction.
* 5 pL Antarctic phosphatase (concentration = 5 u-t; need 5 units per pag vec-
tor
* 20 pL loX Antactic phosphatase buffer
* 175 pL purified vector =pL vector
* 200 p L Total volume
(b) Dephosphorylate for 1.5 hours at 37 0 C. No heat kill necessary.
(c) Using the DNA Gel Extraction Kit from Qiagen (page 19 in the QlAquick Spin
manual), purify the dephosphorylated vector. Elute the purified DNA in 50 pL of
prewarmed EB (microwave for ~ 10 seconds to warm EB to around 50'C). Let the
EB sit on the column for three minutes before eluting. These two steps increase
the yield of DNA.
(d) Measure the concentration and calculate the total mass of DNA for the parental
vector and the insert:
rig_
Dephosph. parental vector: pL x = -ng (4.8)pL
5. Ligation of library oligonucleotide insert and vector
A molar ratio of 1:10 for vector to insert is used and the mass of the library oligonu-
cleotides is 29495 me. For 100 ng of vector, 13.2 ng of insert is needed:
(100 ng vector)(95 bp insert)(10 moles insert) - 13.2 .g insert (4.9)
(7200 bp vector)(1 mole vector)
(a) Dilute insert 1:10 to reach a workable concentration (90 pL EB and 10 PL insert).
Insert conc. = Result from Equation (4.7) x 0.1 g (4.10)
y L
13.2 rig
Volume insert needed iner n pL (4.11)
insert concentration
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Volume for Number of Volume for




T4 DNA Ligase Buffer (10X) 4 20 80
T4 DNA Ligase 2 20 40
ddH2 0 20
Total 40 20 800
Table 4.4: Table for calculating p VIII library ligation reaction volumes
(b) To ligate 2 pug vector use Table 4.4.
(c) Split the reaction into separate PCR tubes with 40 pLin each tube. Incubate the
reaction overnight at 16 C.
Start preparation of an overnight of XL1-Blue cells in 25 mL LB-Tet for Day 2.
END OF DAY 1
(d) Using the DNA Gel Extraction Kit from Qiagen (page 19 in the QlAquick Spin
manual), purify the ligation reaction. Use 4 columns for the purification. Elute
each column of purified DNA in 50 pL of prewarmed EB (microwave for ~ 10
seconds to warm EB to around 50'C). Let the EB sit on the column for three
minutes before eluting. These two steps increase the yield of DNA.
(e) Concentrate the vector using Amicon Ultra 0.5 mL 30K spin column.
(f) Mix all four purifications together = 200 pL and add to spin column.
(g) Centrifugc at 14,000 RCF for 10 minutes. This will reduce the volume to 23
pL.
(h) Add 200 pL EB and centrifuge at 14,000 RCF for 10 minutes.
(i) Flip filter over into a new tube and spin for 2 minutes at 1000 RCF. This should
provide ~ 23 pL concentrated DNA.
(j) Measure the concentration and calculate the total mass of DNA:
Ligated vector: pL x ng
pL
ng (4.12)
6. Transformation of library DNA into electrocompetent E. coli and amplification of
library
This part takes about 7 hours from start to finish.
(a) The ligation reaction will be transformed in 12 separate transformations.The fol-
lowing is needed:
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* 12 14 mL round bottom tubes
* 12 1.5 mL tubes, chilled
* 12 electroporation cuvette, chilled
* 1 kit XL1-Blue electrocompetent E. coli (Agilent 200228)
* 60 mL melted agarose top
* 12 mL warm SOC media
* 2.5 mL of XL1-blue cells (grown overnight from previous day)
* 9 warmed IPTG/Xgal/Tet plates
(b) Thaw cells on ice and aliquot 40 pL cells into each of 12 chilled 1.5 mL tubes.
Keep on ice.
(c) Add 1/12 of the total ligated DNA (between 1.5 and 2.0 pL, depending on final
volume) to each cells and calculate mass of DNA transformed.
Total volume =_ 
_ pL =ng (4.13)
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(d) Transform, according to protocol for cells.
(e) Incubate transformed cells for 45 minutes (from the time the last batch of cells
went into incubator).
(f) Remove cells from shaker and mix all of them together ~ 10.5 mL.
(g) Take 100 iL from pre-amplification cells and set aside for titering. Finish prepar-
ing amplification reaction before returning to titer using Table 4.5 for calculations.
Titering consists of adding 10 pL of phage mixture with 150-200 pLof overnight
XL1-blue cells and 4-5 mL of ~ 50'C agarose top (if it is too hot, it will kill the
cells).
(h) Add all remaining transformed E. coli cells to 400 mL LB with 0.4 mL tetracy-
cline. Amplify at 37'C for 3 hours.
(i) Take a 100 pL aliquot and use for titering. Titering consists of adding 10 pL of
phage mixture with 150-200 pL of overnight XL1-blue cells and 4-5 mL of ~~
50'C agarose top (if it is too hot, it will kill the cells). Use Table 4.5 for calcula-
tions. Place plates in 37'C incubator overnight.
(j) To purify the amplified phage, centrifuge the mixture at 12200 RCF for 30 min-
utes.
(k) Transfer the supernatent into a new tube and add 20% (w/v) polyethylene gly-
col8000, 2.5 M NaCl (PEG/NaCl) (1/6 volume = 75 mL PEG/NaCl). Mix by
inversion and store at 4C overnight.
END OF DAY 2
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(1) Centrifuge the phage mixture at 15900 RCF for 1 hour.
(m) Gently pour off the supernatent.
(n) Resuspend the pellet in 30 mL of IX TBS and transfer to a 40 mL centrifuge
tube.
(o) Centrifuge at 3500 RCF for 10 minutes to remove residual cell material.
(p) Transfer the supernatent to a clean 40 mL centrifuge tube.
(q) Add 1/6 volume PEG/NaCl to the supernatent (5.5 mL) and mix by inversion.
(r) Store at 40 C overnight.
(s) Count plaques from Day 2 titering and calculate amplification ratio.














Table 4.5: Table for calculating p VIII library titering results
END OF DAY 3
(t) Centrifuge phage mixture at 21000 RCF for 45 minutes.
(u) Remove supernatent by decanting, spin again for 2 minutes to pull pellet and
residual liquid to bottom.
(v) Remove residual liquid by pipette and Kimwipe (if necessary).
(w) Resuspend the pellet in 1 mL of IX TBS. Transfer to 1.5 mL tube and centrifuge
at 3500 RCF for 5 minutes to remove last cellular material. Store at 4C in short
term.
(x) For long term storage, add 1:1 volume of glycerol such that the final concentration
is 50% glycerol. Store at -20 C.
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(y) Titer the final library to determine concentration. Titering consists of adding 10
pL of phage mixture with 150-200 pL of overnight XL1-blue cells and 4-5 mL
of ~ 50'C agarose top (if it is too hot, it will kill the cells). Use Table 4.5 for
calculations. Place plates in 37'C incubator overnight.
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Chapter 5




In this work, M13 bacteriophage (M13 phage, or phage) was established as a temperature
stable, highly-multivalent biocatalytic scaffold. A panel of histidine-biased M13 phage was
screened for esterase activity and 2 out of 7 histidine phage enhance the hydrolysis of the
substrate pNPA. The ~c'-- 170 matched that reported for a computationally designed
cat
pNPA hydrolysis enzyme (PZD2) and the Km ~ 4 mM was only 20-fold lower than PZD2. [99]
The esterase phage retained almost 50% of their pNPA hydrolysis activity after a 4-hour,
80'C heat treatment, whereas bCA2, which also catalyzes this reaction, lost 97% of its
activity in just 10 minutes at 80'C. The mechanism of action for esterase activity appears
to be metal-ion-independent, though the histidine phage were shown to bind specifically to
Zn2+, Ni 2+, and Cu 2+, but not to other divalent cations. Future work will be focused on
improving the Km, and Kcat, on identifying other industrially relevant substrates, and on
incorporating metallic centers into the pVIII active sites.
5.2 Introduction
The use of enzymes and other biomolecules as catalysts has been an established tool for
industrial chemical synthesis for over two decades. [100] Recently, biocatalysis has received
renewed attention as the chemical and pharmaceutical industries emphasize "green chem-
istry" for sustainable manufacturing of their products. [101] There is a strong conviction
that, due to innovations in computational optimization algorithms, rational design, directed
evolution, and more efficient screening of higher quality biomolecular libraries, many new
biological catalysts are on the horizon. [102]
There are two general strategies for the developmnet of new biological catalysts, each with
its own tradeoffs. In one, de novo biomolecules are designed and built from scratch, allowing
for complete control over the size, shape, and subcomponents of the biomolecule. [103-109]
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However, there is vast complexity in biomolecules and nearly infinite possible combinations
of amino acids; appropriately incorporating every desired feature when starting from scratch
can be overwhelming. The other seeks to harness Nature's optimization of biomolecules
and to bestow new functionalities on those biomolecules. [99, 110, 111] This allows one to
start with a known entity with a pre-established structure and function (and with a built-in
existence proof), and to focus effort on the desired novel functionalities.
This work takes the second approach, using M13 phage as the starting point. M13 phage
is a rod-shaped virus with a highly ordered viral capsid that can be culture concentrations of
greater than 20 '. The major coat protein (pVIII) has roughly 2700 copies that stack in aL
five-fold symmetry down the length of the virus. This stacking enables regular 3D-ordering
of fusion proteins that are added to the N-terminus of pVIII. [112] As demonstrated in
Chapter 4, it is possible to make biased pVIII libraries, which are naturally endowed with
the repetitive and consistent arrangement of the viral capsid. This appropriately reduces the
sequence space for a library to a subset that is more likely to possess enzymatic activity, since
well folded structures are a prerequisite for such activity. [113,114] Every phage carries its
own genome, meaning that there is a tight genotype-phenotype linkage, which simplifies the
identification of the sequences that are causing activity. With genetically modifiable proteins
on both ends and along the length of the capsid, if a catalytic site could be engineered
into pVIII, it would be possible to make a highly multivalent, multi-functional biocatalytic
molecule. [115, 116] Finally, M13 phage is more stable than many enzymes and proteins
under non-standard conditions, such as high temperatures and low pH - a desirable feature
for industrial catalytic reactions.
Enzymatic hydrolase reactions, including those catalyzed by esterases, lipases, and pro-
teases, constitute a significant fraction of industrial biotransformations. [117] The proof-of-
concept reaction chosen to demonstrate that the pVIII protein on M13 phage can act as a
biocatalyst was the nucleophilic hydrolysis of p-nitrophenyl acetate (pNPA) (see Figure 5.1
for a scheme of the reaction). This reaction was chosen because it proceeds relatively slowly
in neutral aqueous solutions, it has been well-characterized, and it generates a product, p-
nitrophenol (pNP), that can be measured with a spectrophotometer. Also, since carbonic
anhydrase has been shown to catalyze this reaction, there was a readily available positive
control against which any M13 phage results could be benchmarked.





Figure 5.1: Nucleophilic hydrolysis of pNPA Image adapted from [99].
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5.2.1 Active site of carbonic anhydrase and structural analogies
to pVIII protein
In carbonic anhydrase, a coordinated zinc ion acts as a nucleophile to catalyze the hydrolysis
of pNPA. [118] The structure of the active site of hCA2 was used as a model for the design
of an active site on the pVIII protein. In the active site of hCA2, there are three histidine
residues that coordinate the Zn2+ ion (see Figure 5.2a). Two of the histidine residues are on
the same strand and are separated by one residue and the third histidine is on a separate
strand but is in close proximity to the other two (see Figure 5.2b). The structure of the M13
viral capsid is similar to the carbonic anhydrase in that one pVIII protein is arranged in
close proximity with three other pVIII proteins (see Figure 5.2c). The goal of this work was
to build an active site on every copy of pVIII on an assembled M13 phage using the carbonic
anhydrase active site as a model. The histidine-biased libraries built as part of the work
described in Chapter 4 generated hundreds of histidine-biased sequences and it was this set
of sequences that formed the starting point for generating a panel of histidine sequences to
test for pNPA hydrolysis activity.
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N-terminus - A EGD DPAKAAFN S13 L Q15 A S17 A T19 EY G23 YAW A27 M... - C-terminus
xxHxHxxx
Figure 5.2: hCA2 active site compared to four aligned p VIII proteins (a) In the active site
of hCA2, three histidine residues coordinate a zinc ion (PDB 3HS4). This active site can
catalyze the hydrolysis of pNPA. (b) The sequence of the active site of hCA2. Two of the
histidines are on the same strand and the third is on an adjacent strand. (c) Four aligned
strands of pVIII on the surface of M13 virus (from PDB file 1IFJ). [92] The residues that are
highlighted show the six residues that were identified to be tolerant of a histidine mutation.
(d) The first 28 amino acids of pVIII. The three N-terminal amino acids that are replaced
with the 8 amino acid library are highlighted, as are the other 6 amino acids that tolerate a
histidine mutation. Only one backbone mutation was introduced in a design at a time (i.e.,




5.3.1 Engineered histidine phage with enzymatic activity
In the histidine-biased library work in Chapter 4, pVIII libraries with two histidines in the
peptide insert at the N-terminus and a third histidine at the twenty-third residue (G23H) in
the backbone were made. To test the versatility of the pVIII backbone in accepting histidines
at locations other than G23, additional backbone residues were mutated. These mutations
included S13H, Q15H, S17H, G23H, and A27H (N12 was also tested but would not tolerate
a histidine mutation). See Figures 5.2c and 5.2d for locations of the histidine mutations in
the pVIII backbone.
After identifying which backbone residues would tolerate histidine mutations, small-scale
triple-His libraries were made with the 13H, 15H, and 23H backbone mutations using a
scaled-down but similar version of the protocol described in Section 4.5.5. Phage from each
of these libraries were amplified and tested for their ability to catalyze the hydrolysis of
pNPA. The reaction rate was monitored across a range of pNPA concentrations, with each
concentration measured in duplicate for each sample. An example of the raw rate data
for the duplicate samples for a DDAHVHWE-23H phage, a bCA2 positive control, and a
blank reaction (no enzyme) with 4 mM pNPA is shown in Figure 5.3a. For each sample
and each concentration of pNPA, the reaction rate was calculated over the first 30 minutes
of the reaction by fitting a linear regression through the data. Linearity was confirmed
by analysis of the R2 value and by visual inspection of the raw kinetic data. Rates from
replicate wells were averaged and were plotted against substrate concentration (Figure 5.3b).
Rates were converted to 'e"ond as discussed in Section 5.5.3. The blank reaction rate was
subtracted to obtain background-subtracted rates for each sample at each concentration of
substrate. To compare the reaction rate enhancement for a variety of phage sequences, the
average percent rate acceleration was calculated by dividing the rate for each sample at each
substrate concentration by the blank reaction rate at the same substrate concentration. This
value was converted to percent rate acceleration using the following equation:
Percent rate acceleration Ratesample - 1)(100%) (5.1)
Ratebank
The results of this calculation for all the phage sequences tested are shown in Figure 5.4
along with a bCA2 positive control. Nine different phage sequences were tested in total; one
sequence had four histidines (ADHDHHSV-15H), five had three histidines, (DDAHVHWE-
23H, EGHVHATM-23H, ATHDHGDQ-23H, DVHSHGLP-15H, and DMHEHNGE-13H), one
had two histidines (TENMHGTM-23H), one had one histidine (DSPHTELP), and a con-
trol sequence had no histidines (EEE). Only two of the sequences demonstrated activity
over background (DDAHVHWE-23H and TENMHGTM-23H). To assess the biological re-
producibility of these results, the DDAHVHWE-23H phage was amplified and tested three
separate times. The three biological replicates showed similar activities. Note that the pVIII
peptides were present at - 50OX higher concentrations than bCA2 (22.5 pM vs. 45 nM).
In order to better assess the results of the pNPA hydrolysis assay, the enzyme param-
eters were calculated for the sequences that demonstrated activity. For two batches of
DDAHVHWE-23H and for the one batch of TENMHGTP-23H, the Kmn, Keat, Kfat , and
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(b)
4 mM pNPA Blank reaction-1
4 mM pNPA Blank reaction-2
4 mM pNPA 22.5 pM DDAHVHWE-23H-1
4 mM pNPA 22.5 pM DDAHVHWE-23H-2
4 mM pNPA 45 nM bCA2-1
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Figure 5.3: Hydrolysis of pNPA by DDAHVHWE-23H phage (a) The formation of pNP
was measured by monitoring the absorbance at 400 nM. Data from the replicate wells for
a blank reaction, a bCA2 postive control, and a DDAHVHWE-23H phage are shown. (b)
For each concentration of pNPA, the slopes from the raw rate data were calculated for the
first 30 minutes of the reaction. The values from the replicate wells were averaged and the
reaction rate with standard deviations was plotted against the substrate concentration for
each sample. To calculate the fold-improvement over background, the rate for each sample at
each concentration of substrate was divided by the blank reaction rate at the same substrate
concentration. (c) Rates were converted to nM as discussed in Section 5.5.3. The blank































Figure 5.4: pNPA hydrolysis assay results for a panel of engineered histidine phage This fig-
ure. shows the results of the pNPA hydrolysis assay for nine different sequences of engineered
M13 phage and for a bovine carbonic anhydrase (bCA2) control. All phage were tested at
a concentration of 5 x 1012 P , or 22.5 piM pVIII, and the bCA2 was tested at a concen-
tration of 45 nM. Six 23H sequences were tested, two 15H sequences were tested, one 13H
sequence was tested, and two sequences with no backbone histidines were tested (DSPH-
TELP and EEE). Two of the histidine phage increased the reaction rate, DDAHVHWE-23H
and TENMHGTM-23H. Three batches of DDAHVHWE-23H were tested. Each box and
whiskers data point represents rate data from six concentrations of substrate. The ellipse
represents the mean, the boxes the standard deviations and the whiskers the full range of
the data. Each concentration of substrate was measured in duplicate and the rates were
averaged and normalized to the blank reaction rates at that concentration of substrate.
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- were calculated. These results are reported in Table 5.1, where they are benchmarkedKm
against the enzyme parameters of other enzymes that can catalyze pNPA hydrolysis. In
2001, Bolon, et al., engineered a pNPA hydrolysis site into a thioredoxin scaffold (PZD2)
and their results are presented in Table 5.1 along with the engineered phage results. Also,
the bCA2 positive control results from this work and from previous reports are included in
Table 5.1. The bCA2 parameters calculated in this work match well with those reported in
the literature, validating the 96-well pNPA plate assay developed as part of this work.
Sample Km (mM) Kcat (-;) "((M) (ec) Source
______sec__ Kuncat Km. ((M)(sec)
DDAHVHWE- 7.1 + 0.3 8.3 i 0.25 x 10-4 168 ± 5 0.12 ± 0.004 this study
23H (batch 1)
DDAHVHWE- 4.0 ± 1.7 4.7 i 1.1 x 10-4 98 ± 24 0.12 ± 0.03 this study
23H (batch 3) 1
TENMHGTM- 4.1 ± 0.4 8.4 t 0.45 x 10-4 170 ± 9 0.21 ± 0.01 this study
23H
Engineered
thioredoxin 0.17 ± 0.02 4.6 0.2 x 10-4 180 2.71 [99]
(PZD2)
bCA2 31.4 ± 7.26 7.8 ± 1.7 1.6 ± 0.34 x 106 248 ± 54 this study
literature value 9.2 2.45 6 x 105  266 [119]
Table 5.1: Enzyme parameters for pNPA hydrolysis by engineered phage All values reported
for engineered phage are reported per pVIII protein, not per phage molecule. The engineered
phage have Kcat values that are comparable with PZD2, a thioredoxin engineered to have
pNPA hydrolysis activity. The Km and -^'g values for the engineered phage are only ~ one
order of magnitude worse than that of PZD2.
The engineered phage have Kcat values that are comparable with PZD2 and Km values
that are only loX higher - impressive results considering that PZD2 was rationally designed
to catalyze this reaction, while the engineered phage were identified in a screen of just a few
sequences. All values reported for engineered phage are reported per pVIII protein, not per
phage molecule. If the same parameters were calculated per phage molecule the values are
very close to that of bCA2 (M13 Kcat = 1.3-2.3 - and M13 K, = 2.7-4.6 x 105).
sec Kuncat
Interestingly, the active phage sequences did not have any Zn2+ added to them (beyond
what is present in the bacterial growth media), meaning that the mechanism of hydrolysis
may be different from that of bCA2. While further experiments will clarify the exact mech-
anism, it appears likely that the histidines themselves are the active site (see the discussion
in Section 5.4).
5.3.2 High temperature stability of enzymatic phage
After identifying two pVIII sequences that could catalyze the hydrolysis of pNPA, the tem-
perature stability of the enzymatic phage was tested. First, DDAHVHWE-23H and bCA2
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were subjected to a 10-minute treatment at 80'C in a PCR thermocycler, much like one
might treat an enzyme to perform a heat kill during a cloning experiment. The pNPA hy-
drolysis activities of bCA2 and DDAHVHWE were compared before and after the 80 0C heat
treatment. The bCA2 sample lost nearly all of its activity, while the DDAHVHWE-23H
sample retained most of its activity. Figure 5.5a shows these results.
After demonstrating that the DDAHVHWE-23H phage retained enzymatic activity after
a 10 minutes heat treatment at 80'C, DDAHVHWE-23H and TENMHGTM-23H phage were
exposed to 1 hour and 4 hour heat treatments at 80 C. The results of this experiment are
shown in Figure 5.5b and are summarized in Table 5.2. Both phage sequences retained at
least 45% of their pNPA hydrolysis activity even after 4 hours of exposure to 80'C, while
the bCA2 sample lost 97% of its pNPA hydrolysis activity after just 10 minutes at 80'C.
Sample Time at 80'C (hours) Percent activity retained






**0.17 hour data and 2 hour, 4 hour data from separate experiments
Table 5.2: Stability at 80'C for enzymatic phage compared to bCA2 Percent activity retained
was calculated using the average percent rate acceleration value (the ellipses in Figure 5.5)
normalized to the no-heat-treatment value for each sample.
5.3.3 Transition metal ion binding by engineered histidine phage
The capacity to engineer a histidine-based active site onto every copy of the surface coat
protein pVIII and the subsequent resistance to high temperature treatment establishes M13
phage as a scaffold for enzymatic reactions. However, a larger suite of catalytic reactions
would be accessible if bioinorganic active sites with coordinated metal ions could be engi-
neered onto pVIII. [90] Metal ions play several roles in biomolecules and the coordination
chemistry is a determining factor for which role they play. For example, Zn 2 + has four co-
ordination sites. If all four of those coordination sites are occupied by organic ligands (four
amino acids), then the Zn 2 + is playing a structural role in the protein. If, however, three
of those sites are occupied by the imidazole ligand of histidine residues and the fourth is
occupied by a water molecule, then the Zn 2 + site can act as a catalytic site. [120
The metal ion binding capacity of the histidine phage was explored using a Nanotember
Monolith microscale thermophoresis (MST) instrument. MST is based on the movement of
molecules in microscopic temperature gradients, and it provides information about molecule
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Figure 5.5: Stability of enzymatic phage at 80'C (a) The temperature stability of
DDAHVHWE-23H phage was compared to bCA2 assessing the pNPA hydrolysis activity of
each biomolecule before and after a ten minute 80'C heat treatment. Activity was measured
using pNPA assay with phage at a concentration of 22.5 pM pVIII. (b) The temperature
stability of DDAHVHWE-23H and TENMHGTM-23H phage was tested by measuring the
activity of the phage before and after 80'C heat treatments. Activity was measured using
pNPA assay with phage at a concentration of 4.5 pM pVIII. Each box and whiskers data
point represents rate data from six concentrations of substrate. The ellipse represents the
mean, the boxes the standard deviations and the whiskers the full range of the data. Each
concentration of substrate was measured in duplicate, averaged, and normalized to the blank
reaction at that concentration of substrate.
113
binding events, including protein-protein, protein-small molecule, and protein-ion interac-
tions and a full description of the technique is available elsewhere. [121, 122] Briefly, a flu-
orescently labelled protein (in this case, M13 phage) is loaded into a glass capillary. An
infrared laser is used to heat a small section of the capillary (Figure 5.6a) and the mobility
of the protein is measured by monitoring the change in fluorescence. A set of 16 protein
samples (all at the same concentration) are mixed with a serially-diluted binding partner (in
this case, metal ions) in 16 different glass capillaries. In the samples where the concentration
of the binding partner is higher than the KD of the binding interaction, the thermophoretic
mobility of the protein changes. Plotting the thermophoretic mobility of the protein against
the concentration of the binding partner for all 16 samples provides data like that shown in
Figure 5.7a, which approximates a characteristic binding curve.
The binding of four different engineered M13 phage to Zn2+ was tested using MST.
Zn 2+ was titrated from 250 pM to 0.01 pM. For all three of the triple-His phage (DDAHVHWE-
23H, ESHTHGNE-23H, and EAHAHGDE-23H) there was an interaction with the Zn2+ at
around 7-20 MM Zn2+(see Figure 5.7a). The negatively charged EEE phage did not exhibit
any change in thermophoretic mobility across the range of Zn 2+ concentrations tested. His-
tidine residues are well know for their ability to interact with Zn2+, as well as with other
first row transition metals, whereas histidines do not typically interact with the divalent
cations Ca2+ or Mg2+. The binding of DDAHVHWE-23H phage to five divalent cations was
measured using MST. The DDAHVHWE-23H phage showed ion-specific binding with the
three transition metals, Zn 2 +, Cu 2+, and Ni 2+, but not with Ca2+ or Mg 2+.
In all of the experiments where the phage was interacting with the metal ions (i.e., for
all binding experiments between three triple-His sequences and Zn2+, Cu 2+, or Ni2 +), the
MST traces looked like the one shown in Figure 5.6b. According to the Nanotemper product
literature, the irregularity of the shapes of MST curves (compare the typical curve from the
Nanotemper product literature in Figure 5.6a to the curves in Figure 5.6b) indicate that the
Zn2+ was inducing aggregation of the phage. To further investigate this, the pNPA hydrolysis
activity of DDAHVHWE-23H phage was tested in the presence of 0 mM Zn2+, 0.1 mM Zn2+,
and 1 mM Zn2+ (see Figure 5.7c). At 100 piM Zn2+ (well above the measured KD), the pNPA
hydrolysis activity was severely quenched. At 1 mM Zn2+, the raw absorbance data became
very bumpy, leading to the very high standard deviation for the processed rate acceleration
data shown in Figure 5.7c.
The DDAHVHWE-23H, 1 mM Zn2+ and 0 mM Zn 2 + samples were also examined under
AFM. Ten pL of each sample (aliquots taken prior to pNPA hydrolysis assay) was deposited
onto an AFM disk and allowed to dry. The AFM images for the 0 mM Zn 2+ samples are
shown in Figures 5.8a and b. The features are typical AFM images of M13 phage, with some
small clumps of virus (left side in a and bottom right in b), but with a significant number
of phage (rod-like structures) spread out across the surface. The 1 mM Zn 2 + samples in
Figure 5.8c and d, however, are unusual for AFM images of M13 phage. The entire AFM
substrate surface is covered in large clumps of material, which, when examined at a higher














Figure 5.6: Explanation of Microscale Thermophoresis (a) Before temperature change,
the molecules are homogeneously distributed and a constant fluorescent signal is mea-
sured. When the laser is turned on, a fast temperature jump is observed, followed by
thermophoretic molecular motion. The fluorescence decrease is measured for 30 seconds.
When the laser is turned off, an inverse temperature jump is observed, followed by the
diffusion of molecules, which is purely driven by mass diffusion. The curve on the right
is a typical MST curve from the Nanotemper product literature. Figure and explanation
from [122]. (b) An example of MST data from a DDAHVHWE-23H and Zn 2+ binding
interaction experiment. Each trace represents data from a different capillary (Zn 2+ was
serially diluted across 16 capillaries). At a critical concentration of Zn2+ the traces stop
looking like a "normal" trace, like the example on the right in (a), and start to ex-
hibit bumpiness, which is indicative of sample aggregation. To identify this critical con-
centration of Zn 2+, the change in fluorescence was calculated using temperature jump
data for each sample (MST Temp Jump = (Ave. fluor. signal between vertical blue lines) -
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Figure 5.7: Engineered phage bind transition metals, aggregate, and lose pNPA hydrolysis ac-
tivity (a) The thermophoretic mobility of four strains of engineered phage were tested across
a range of Zn2+ concentrations. All three triple-His phage exhibited binding to Zn2+ with
KD's between 6 and 20 pM. (b) DDAHVHWE-23H binds the first-row transition metals Zn 2 +,
Ni2+, and Cu2+, but not Ca2+ or Mg2+. (c) Zn 2+-induced aggregation of DDAHVHWE-23H
leads to a loss of pNPA hydrolysis activity. Each box and whiskers data point represents
rate data from six concentrations of substrate. The ellipse represents the mean, the boxes
the standard deviations and the whiskers the full range of the data. Each concentration of
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Figure 5.8: AFM images of Zn2+ induced aggregation of DDAHVHWE-23H (a) and (b) AFM
amplitude images of DDHAVHWE-23H phage with no ZnCl2 . There are some clumps of ma-
terial (which are often present in M13 AFM images, due to drying effects), but a lot of individ-
ual rod-like shapes (M13 phage). (c) and (d) AFM amplitude images of DDHAVHWE-23H
phage with 1 mM ZnCl2 . Note that the AFM substrate surface is almost entirely covered
with material. The image in (d) is a higher zoom image of the top right corner from (c) and
shows some individual phage, but the majority appear to be aggregated together. Both M13
phage samples came from the same stock solution and were handled exactly the same, with
the only exception being the amount of Zn2+ added to the samples.
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5.4 Conclusions
The results of this work firmly establish M13 phage as a highly multivalent, temperature-
stable scaffold for biocatalysis. While the results indicated that the esterase activity is
independent of zinc, which would suggest that the histidines are themselves the active site,
this mechanism needs to be confirmed. Bifunctional catalysis of ester hydrolysis by two
histidines has been previously reported, with one "acting in the free base form as the nucle-
ophilic or general-base catalyst and another acting in the protonated form, for example, in
stabilizing the oxyanion intermediate" [123]. In a de novo designed 42-amino acid polypep-
tide that folded into a four-helix bundle, it was demonstrated that a two-histidine active
site, with one His residue protonated and the other unprotonated, functioned through coop-
erative nucleophilic and general-acid catalysis. [124] The distance between the histidines and
the nature of the surrounding residues were critical parameters in tuning the activity of the
peptide, which is consistent with the fact that esterase activity was only measured in two
of the M13 phage tested in this work. In fact, it turns out that a two-histidine active site
is a common motif that has been used to validate other proteins as scaffolds for engineered
enzymatic activity. Bolon and Mayo used computational design to identify mutations in
a thioredoxin protein that would enable zinc-independent, histidine-mediated nucleophilic
hydrolysis of pNPA and Host, et al., created a novel esterase by adding a two-histidine re-
active site into a well-defined substrate binding site. [99,125] Bolon and Mayo's results are
presented in this work as a benchmark for engineered esterase activity in Table 5.1.
In this work two pVIII sequences that had esterase activity were identified from a panel
of just seven sequences. A success rate of > 20% is unusual in library screening projects.
However, it should be made clear that the M13 phage that were chosen for analysis were
culled from the hundreds of phage that were sequenced based on some underlying rules-of-
thumb for biocatalytic activity. First, the active site sequence of hCA2 was used as a model
and sequences that looked similar, especially with regard to the histidine-adjacent residues
were chosen. For example, in hCA2, the three residues around H9 4 and H96 are FHFHW
and it has been shown previously there is a relationship between the hydrophobicity of these
surrounding residues and the esterase activity of the enzyme. [126] It also has been noted
that metal ions often bind in hydrophobic cores. [127} In other words, the results of this work
were not the results from a random panel of sequences; the M13 phage sequences that were
chosen in this work were chosen because of their perceived adherence to these rules (i.e., at
an amino acid level DDAHVHWE looks like FHFHW).
Even with this preselection bias in the panel of tested phage, the hit rate is still high.
Others have previously reported, though, on the catalytic abilities of de novo proteins that
were designed only for structure, with no function in mind and that were not exposed to evo-
lutionary pressure. [128] In that work, 30% of the tested proteins displayed esterase activity
and 20% displayed lipase activity. In fact, it has been hypothesized that this feature (i.e.,
promiscuous, low-level catalytic activity) could have served as a central node for evolution
in nature. [129]
Further work will need to be performed to verify that there is truly no metallic center
in the active sites of the pVIII proteins. Also, an alanine scan of all of the residues in the 8
peptide insert and of the histidine in the backbone should offer more insight into the roles
of each amino acid. Future work will use 4-methylimidazole as a control for the histidine
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residue without the surrounding phage sequence and the active pVIII insert sequences will
be tested in solution to determine the contribution of the viral capsid structure to activity.
Finally, future work should focus on examining activity in other assays (like lipases and
heme binding) and on improving the Km and Kcat of the enzymatic phage to make them
more appealing for industrial chemical synthesis.
5.5 Experimental
5.5.1 Phage preparation
Phage clones were picked from individual plaques off of a titering plate and were amplified
for 6 hours at 37'C in a culture of XL1-Blue E. coli cells. The culture was made by adding
40 pL of an overnight culture of XL1-Blue cells and 4 pL of 20 9 tetracycline to 4 mL of
LB. After amplification, the cells were pelleted. Double-stranded DNA was purified from
the cells using a Qiagen plasmid prep kit and was sequenced with a neg96gIII primer (New
England Biolabs) to confirm that the correct pVIII sequence. The 4 mL supernatent was
retained and used to seed a 1 L XL1-Blue E. coli culture. The phage were amplified for 8
hours to overnight. After amplification, the culture was centrifuged at 12200 RCF for 30
minutes. A small part of the pellet was retained and double-stranded DNA was purified
and sequenced as before to confirm the correct sequence. To the supernatent a 1/6 (volume
to volume) amount of 20% (w/v) polyethylene glycol8000, 2.5 M NaCl (PEG/NaCl) was
added. The sample was mixed by inversion and stored overnight at 4C. The next morning
the sample was centrifuged at 15900 RCF for 1 hour. The supernatent was removed by
decanting, the pellet was resuspended in 30 mL of IX TBS and was transferred to a clean
40 mL centrifuge tube. The tube was centrifuged at 3500 RCF for 10 minutes to remove
residual cell material and was then transferred to another clean 40 mL centrifuge tube. A 1/6
volume of PEG/NaCl was added. The sample was mixed by inversion and stored overnight
at 40C. The next day, the samples were centrifuged at 21000 RCF for 45 minutes and the
supernatent was removed by decanting. The tube was centrifuged again for 2 minutes to pull
the pellet and residual liquid to the bottom. The residual liquid was removed and the pellet
was resuspended in 1 mL of 50 mL Tris-sulfate, pH 7.6. The concentration was measured
by UV-Vis absorbance.
5.5.2 pNPA assay
Two-fold serial dilutions of pNPA (Sigma number: N8130) were made in DMSO from 80 mM
to 2.5 mM and were stored at 4C in sealed tubes. Bovine carbonic anhydrase was purchased
from Worthington Enzymes, was resuspended in ultrapure water and was stored in 0.1 L
aliquots at -20'C. Just prior to testing, bCA2 was diluted to the appropriate concentration
in Tris-sulfate, pH 7.6. To set up the assay, 10 pL each of the different concentrations of
pNPA was added to separate wells in a 96-well plate. For each sample to be tested (blank,
bCA2, phage), two replicate concentrations of pNPA were prepared. To initiate the assay,
a multichannel pipette was used to add 190 [pL of phage, bCA2, or buffer only to each well.
Each well was mixed by aspirating and dispensing gently. The absorbance at 400 nm was
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read in kinetic mode in a plate reader at 25C. The slopes of the A400 change were calculated
for 30 minutes of reaction (during which the reaction remained in the linear phase).
5.5.3 Calculating enzyme parameters
To convert rate units from A400 per second to nM per second, the following equation was
used
(AD)(109 nM)
sec __ M (5.2)(pNPA extinction coefficient)(Path length)
where the extinction coefficient is 18,400 1 and the path length is estimated to be
0.6 cm for 200 pL of liquid in a 96-well plate well. To calculate the kuncat, the following
equation was used
kun=at Rateuncatalyzed 5.3)pNPA concentration
where the uncatalyzed reaction rate was the rate of the buffer only samples. The average
kuncat was calculated across all substrate concentrations. To determine Vmax and KD, the
data was fit using QTI plot to the Michealis-Menten equation:
(Vmax) (x)
y = ((5.4)(Kai + x)
where Vmax = (kcat)([E]), x = [S], and Km is equal to the substrate concentration at which
the reaction rate is half of the Vmax.
5.5.4 Labeling triple-His phage with AF488 for MST experiments
To 200 pL of phage in IX PBS, 300 pL of PBS, and 20 pL of 10 m"9 AF488-5-SDP (Invitrogen)
was added. The reaction was allowed to proceed for 1.5 hours at room temperature under
slight agitation. Then the samples were dialyzed to remove the unreacted dye against 5
L of IX PBS overnight. The PBS was exchanged twice the next day for two more 3 hour
dialyses. Finally, a 1/6 volume of PEG/NaCl was added to the solution in the dialysis tubing
and it was transferred to a 1.5 mL tube and stored at 40 C overnight. The next day, the
samples were spun at 18,000 RCF for 20 minutes. The supernatent was removed and the
samples were resuspended in 1X TBS. The concentrations were measured and the removal
of unconjugated dye was confirmed by comparing the absorbances at 269 nm, 320 nm, and
495 nm (absorption peak for AF488).
5.5.5 MST experiments
Samples were prepared according to protocol for MST instrument. Briefly, the fluorescently
labeled phage samples were diluted to roughly 1.1 pM pVIII (for histidine phage) or 10
pM pVIII (for EEE phage) in sample buffer. To 10 pL of phage was added 10 pL of metal
ion in the sample buffer. Samples were read with 100% blue LED power and 40% laser power.
120
Data was analyzed using Nanotemper Analysis software 1.2.095. Since the histidine phage
aggregated in the presence of the first row transition metals because aggregation causes
large variations in the fluorescence signal traces (see Figure 5.6c for an example), it was
not possible to use the thermophoretic mobility to calculate binding affinity. The change in
the fluorescence after the temperature jump (the difference between the average fluorescence
between the red lines and the blue lines in Figure 5.6c) was used to calculate the binding
affinity for the phage and the metal ions; this approach is a valid alternative for analyzing
aggregated samples, per the Nanotemper User Manual. To calculate K, data was fitted to
a Boltzman curve in QTI Plot using the following equation:
(Bottom) - (Top)
- 1 + e((x-KD)(SIOPC)+(TOP)) (5.5)
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